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Abstract   
 
FucoPol is an exopolysaccharide produced by the Enterobacter A47, using glycerol byproduct from 
the biodiesel industry as carbon source. In this work, the potential of this biopolymer to produce 
microparticles and to encapsulate bioactive compounds by spray drying was studied. The particles were 
characterized in terms of morphology (Scanning Electron Microscopy), crystallinity (X-Ray Diffraction), 
chemical characteristics (Fourier Transform Infrared), and thermal properties (Thermogravimetric 
Analysis and Differential Scanning Calorimetry). FucoPol was able to form spherical microcapsules (size 
from 0.5 to 26.7 µm) with a thin wall (thickness from 222 to 1094 nm) and a smooth surface. A population 
of small particles with dented surfaces was obtained. The microcapsules presented an amorphous 
structure.  
Gallic acid (GA) and oregano essential oil (OEO) were encapsulated using FucoPol as wall material. 
The bioactive loading was 12.2 wt.% and 3.1 wt.% for OEO and GA, respectively. Additionally, the 
encapsulation efficiency was 20% for OEO and 5.3% for GA. The release profile in simulated gastric 
(SGF) and intestinal (SIF) fluids revealed a total release, except for the GA in SGF, where 68% retention 
was observed. The compounds antioxidant capacity was not affected by the encapsulation process. 
From the results obtained, FucoPol reveals a good potential as microcapsules forming and 
encapsulating material.  
 
Keywords: FucoPol, Spray drying, Microencapsulation, Gallic acid, Oregano essential oil 
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Resumo  
 
O FucoPol é um exopolissacárido produzido pela bactéria Enterobacter A47, utilizando glicerol, 
subproduto da indústria do biodiesel, como fonte de carbono. Neste trabalho estudou-se o potencial 
deste biopolímero para a produção de micropartículas e consequente encapsulação de compostos 
bioativos pelo método de secagem por atomização. As partículas foram caracterizadas em termos de 
morfologia (Scanning Electron Microscopy), cristalinidade (X-Ray Diffraction), características química 
(Fourier Transform Infrared) e propriedades térmicas (Differential Scanning Calorimetry). O FucoPol 
demonstrou capacidade para formar micropartículas esféricas (de tamanho entre 0,5 a 26,7 µm), com 
parede fina (espessura entre 222 e 1094 nm) e superfície lisa. Obteve-se uma população de pequenas 
partículas com superfícies dentadas. As micropartículas apresentaram uma estrutura amorfa.  
Ácido gálico (AG) e óleo essencial de orégão (OEO) foram encapsulados, utilizando o FucoPol como 
matriz. A carga bioativa destes compostos foi de 12,2 wt.% e 3,1 wt.% para o OEO e AG, 
respetivamente. Adicionalmente, a eficiência de encapsulação foi de 20% para o OEO e 5,3% para o 
AG. O perfil de libertação em fluido gástrico (FG) e intestinal (FI) revelou uma libertação total destes 
compostos, exceto para o AG em FG, onde foi observada a retenção de 68%. A capacidade 
antioxidante dos compostos manteve-se após o processo de encapsulamento. A partir dos resultados 
obtidos, o FucoPol revelou elevado potencial para o uso em encapsulados.  
  
Palavras-chave: FucoPol, Secagem por atomização, Microencapsulação, Ácido gálico, Óleo essencial 
de orégão 
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Resumo Alargado 
 
Alguns compostos utilizados na indústria alimentar, particularmente no que se refere à sua 
bioatividade, são instáveis quando submetidos ao processamento industrial, e a condições de 
transporte e armazenamento, com consequente impacto negativo nas suas propriedades. Como meio 
de proteção destes compostos e de forma a aumentar a sua estabilidade, tem vindo a ser estudado o 
processo de encapsulamento. A técnica mais usualmente aplicada para o microencapsulamento é a 
secagem por atomização, sendo reportado na literatura a utilização de um vasto número de matrizes 
encapsulantes (materiais de parede), como é o caso dos polissacáridos (p.e. amido, maltodextrinas, 
goma arábica e inulina) e proteínas (p.e. gelatina e proteínas do leite). Estes materiais são usados para 
encapsular uma variedade de compostos bioativos, como compostos fenólicos, vitaminas, lípidos, óleos 
essenciais, entre outros.  
O presente estudo é focado na avaliação do potencial de um novo exopolissacárido microbiano, o 
FucoPol, como matriz encapsulante. Este biopolímero produzido pela bactéria Enterobacter A47 (DSM 
23139) tem como vantagem comparativamente com outros, a utilização do glicerol, como fonte de 
carbono. Apresenta um peso molecular elevado (4.19 x 106 – 5.80 x 106), encontrando na sua 
composição grupos acilo (piruvato, succinato e acetato), que conferem ao biopolímero um caracter 
aniónico, e a sua composição é rica em resíduos de açúcar (fucose, galactose, glucose e ácido 
glucurónico), o que lhe atribui um valor acrescentado no mercado.  
Com o intuito de produzir partículas utilizando o FucoPol como matriz foi elaborado um desenho 
factorial, com três variáveis independentes: a concentração de FucoPol (1 e 2 wt.%), a temperatura de 
alimentação (20 ºC e 60 ºC) e a temperatura de entrada do ar de secagem (150 ºC e 200 ºC). Todas 
as partículas foram caracterizadas em termos de morfologia (Scanning Electron Microscopy - SEM), 
propriedades térmicas (Dynamic Scanning Calorimetry - DSC), cristalinidade (X-Ray diffraction - XRD) 
e estrutura química (Fourier Transform Infrared Spectroscopy - FTIR). Este biopolímero demonstrou 
grande potencial na formação de micropartículas pelo processo de secagem por atomização. As 
diferentes formulações de secagem, não atribuíram às partículas morfologias diferentes, sendo que 
exibem um diâmetro médio de cerca de 0,5 µm a 26,7 µm, e espessura de parede irregular que varia 
entre 222 nm a 1094 nm. As partículas apresentam morfologia esférica, com paredes lisas, sem 
buracos, no entanto em torno destas é possível denotar a presença de outras partículas mais pequenas 
com superfícies dentadas. 
Sendo o objetivo deste trabalho definir o comportamento do FucoPol como matriz encapsulante, foi 
selecionada uma das formulações (concentração de 2%, temperatura de secagem de 200 ºC e 
temperatura de alimentação de 20 ºC) para encapsular dois modelos de compostos bioativos, 
nomeadamente, o ácido gálico e o óleo essencial de orégão. Estas partículas foram caracterizadas de 
acordo com as mesmas metodologias acima referidas, obtendo-se morfologias muito similares. No 
entanto, apresentam um tamanho médio de partícula mais pequeno e uma parede de maior espessura 
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comparativamente com o biopolímero sem compostos bioativos. Por sua vez, as partículas de óleo 
essencial exibem cavidades dentro das paredes que podem ser atribuídas a gotículas de óleo que se 
encontram aprisionadas nestas. 
As análises de DSC, XRD e FTIR das partículas com compostos bioativos vieram confirmar os 
resultados obtidos por SEM. Estes testes evidenciaram a presença dos compostos dentro das 
partículas de FucoPol e consequentemente a sua estabilidade térmica. No caso do ácido gálico, foi 
observado a existência de interações com a matriz, provando a maior retenção deste composto no seu 
interior. 
Foram igualmente realizados estudos de libertação in vitro, simulando o comportamento dos 
encapsulados incorporados num meio líquido e observando o que ocorre dentro do trato 
gastrointestinal, particularmente, em dois meios distintos: fluido gástrico (pH=1.2) e intestinal (pH=6.8). 
A partir dos ensaios realizados foram demonstrados vários perfis consoante o composto encapsulado. 
A massa de óleo essencial encapsulado no FucoPol foi totalmente libertada após 35 minutos em ambos 
os meios de libertação. Quanto ao ácido gálico este comportou-se de maneira diferente, uma vez que 
foram apenas necessário poucos segundos, em meio neutro, para que ocorresse a total libertação 
deste composto. No entanto, em meio ácido a maioria do ácido gálico foi retido nas cápsulas (68%). 
Estes diferentes perfis de libertação encontrados com os dois compostos provam que, existem 
diferentes interações entre o FucoPol e os compostos encapsulados de acordo com o meio no qual são 
inseridos.  
De acordo com a microscopia ótica foi possível perceber quais os mecanismos de libertação que 
ocorreram durante os ensaios de libertação em ambos os meios. Os compostos no interior das 
partículas são libertados por uma combinação de vários sistemas, nomeadamente, difusão, inchamento 
e degradação mecânica da própria matriz.  
O sucesso do encapsulamento definido durante todo o estudo foi confirmado pela avaliação do 
potencial antioxidante. Foram aplicados dois métodos distintos, o DPPH e o FRAP, os quais 
demonstraram que após o encapsulamento, a atividade antioxidante dos compostos é mantida. O 
FucoPol é capaz de proteger estes compostos e entrega-los, no local de ação e tempo específico dentro 
do corpo humano, sem que haja degradação das suas propriedades antioxidantes.  
 
Palavras-chave: FucoPol, Secagem por atomização, Microencapsulação, Ácido gálico, Óleo essencial 
de orégão 
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Chapter 1 – Introduction 
 
1.1. Background and motivations  
Nowadays the awareness of consumers for concept of functional foods products has been 
increasing, relating them to a healthy diet. There are various functional food ingredients, such as 
vitamins (ascorbic acid (vitamin C), vitamin D, and vitamin A), lipids (omega 3 and omega 6), minerals 
and probiotics. These ingredients are naturally present in food raw materials, or may be added upon 
processing. However, for these compounds to be effective, their bioactive properties must remain 
unchanged, during processing, distribution and storage, until consumption. In addition to that, after 
consumption, the bioactive compounds should remain stable through the intestinal tract before being 
absorbed into the blood. We have assisted to large amount of research works concerning the 
development of food-grade systems to protect and deliver bioactive compounds, at a specific rate and 
in a specific local of the consumer’s body. 
Most of the bioactive compounds are unstable and easily degraded by environmental factors (e.g. 
pH, light, oxygen, moisture), making this a challenge in the food engineering. Therefore, the main 
objective of researchers in this field is to develop delivery systems that protect the compounds and, at 
the same time, do not adversely affect the properties of the food product, in which they are incorporated.  
The encapsulation process has been widely studied for that purpose, in which the bioactive 
compounds, also named as the core material, are entrapped inside a matrix, also called wall material.   
The selection of the wall materials that will protect the active substances is an essential point for the 
success of the encapsulation process. The literature reports numerous generally recognized as safe 
materials that have been testes, belonging to the classes of polymers, lipids and proteins.  
The natural polymers, biomaterials obtained from living organisms (e.g. plants, animals, 
microorganisms and algae), are the most commonly used materials, due to their interesting properties 
(e.g. chemical, physical and thermal).  
Although exists a vast number of natural polymers, the microbial polysaccharides, such as 
extracellular polysaccharides (EPS), are becoming to gain interest in the studies of this field. This 
attention emerged due to their advantages over the polysaccharides extracted from plant, algae and 
animals sources. The possibility to control their production process enables a constant production rate 
and a product with a low variability of its properties over the year, which are independent of the climatic 
conditions. In addition, polysaccharides with novel and/or improved properties may be obtained by 
modifying the fermentation conditions. The main constraints of microbial production of polysaccharides 
rely on the production costs, largely due to the substrate costs, as the most used are pure sugars like 
sucrose and glucose. As a consequence, only a few number of these biopolymer
Chapter 1.  Introduction                                                 FucoPol as encapsulating matrix of bioactive compounds 
__________________________________________________________________________________________ 
 
2 
 
are produced at an industrial scale displaying a significant commercial value (e.g. xanthan, gellan, 
pullan).  
Recently, the production of a new exopolysaccharide named FucoPol, has been studied aiming the 
optimization of the production process parameters. A low cost alternative substrate source has been 
used, the glycerol, byproduct from the biodiesel industry, with the goal of decreasing the production 
costs. FucoPol is composed of sugar monomers (fucose, galactose, glucose), glucuronic acid and acyl 
groups (acetyl, pyruvly and succinyl). It has demonstrated film-forming and emulsion stabilizing 
capacities. In addition, it contains fucose, in a higher amount to that encountered in other natural 
polysaccharides, referred so far in the literature. From this, there is a good potential for FucoPol to 
present biological properties (e.g. anti-ageing, anti-inflammatory and anti-carcinogenic), which are 
referred in the literature for fucose containing biopolymers. 
Considering the above mentioned, the main objective of this work is to study the potential of FucoPol 
to produce microparticles and its suitability to be applied as encapsulation matrix of bioactive 
compounds.  
The selection of a good matrix (wall material) that allows an efficient protection and release of the 
bioactive compounds, is necessary to take into account its properties, the encapsulation process 
parameters and the physical and chemical characteristics of the core material. Therefore, in this study 
the specific objectives were: 
 To study the potential of FucoPol to produce microparticles by spray drying, by varying process 
parameters: FucoPol concentration in the feed, feed rate and drying temperature; 
 
 To characterize the FucoPol particles produced in terms of morphology, crystallinity, chemical 
characteristics and thermal properties; 
 
 To evaluate the performance of FucoPol as encapsulation matrix of two model bioactive substances: 
gallic acid and oregano essential oil; 
 
 To study the bioactives release rate, in vitro, in simulated gastric and intestinal fluids.   
 
 
1.2. Thesis outline 
This thesis is divided in five chapters. The introduction, which is the Chapter 1, presents an overview 
of the work performed. Chapter 2 describes the state of the art and the main concepts and definitions 
that are usually employed on the subject of this thesis, based on a literature review. Chapters 3 and 4 
present the materials and methods, as the results and discussion, respectively, either concerning the 
viability of FucoPol for producing microparticles, or regarding the encapsulation and release studies. 
Chapter 5 presents the main conclusions and suggestions for future work.  
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Chapter 2 - Literature Review 
 
2.1. Encapsulation process 
There is a global trend by consumers, to which the food industry has joined, wherein foods, in addition 
to providing the basic nutritional functions, also have the ability to produce positive effects on health, 
namely the prevention of some diseases, which are denominated by functional foods (Champagne and 
Fustier, 2007). There are many bioactive compounds used in functional foods that contribute for this 
advantages, including vitamins, flavors, minerals, phenolic compounds, carotenoids, essential oils, fatty 
acids, living cells (e.g.: probiotics), lipids and other ingredients (Kris-Etherton et al., 2002). However, 
these compounds may be unstable and/or decompose when subjected to industrial processing and to 
conditions of transport and storage (such as: light, heat, pressure and oxygen), with a negative impact 
in their bioactive properties (Champagne and Fustier, 2007).  
In order to increase the effectiveness and avoid nutritional and functional losses, the rate at which 
the chemical and biological degradation take place should be minimized. Thus, a new strategy emerged 
to protect bioactive compounds, in order to increase their stability: the encapsulation (Shahide and Han, 
1993; Medeiros, 2013). Encapsulation ensures that they remain active at the time of consumption and, 
after consumption they are protected and released at a suitable rate in a specific region of the 
gastrointestinal tract (Gouin, 2004; Loksuwan, 2007; Estevinho et al., 2013).  
The encapsulation process involves the production of structures, in which the active ingredient, in 
the solid, liquid or gas phase (also mentioned in the literature as core material), is entrapped in a material 
(also referred as coating, matrix, membrane or wall material) (Campos et al., 2013). These structures 
containing inside the bioactive compound, may present a wide range of morphologies and sizes. In 
terms of size, it may vary from nanometer to the micrometer range. This work is focused on the particles 
with size in the range of microns, typically from 1 µm to 1000 µm, named microparticles. 
These microparticles are usually formed by a polymeric matrix, which forms a barrier where a certain 
amount of bioactive compound may be immobilized. According to the distribution of the bioactive 
compound, two different categories of microparticles can be defined: microspheres (Figure 1: A) and 
microcapsules (Figure 1: B). Microspheres are structures composed by a homogeneous mixture of the 
bioactive compound within the matrix, i.e., there is a single phase where the active ingredient is 
dispersed throughout the matrix. The microcapsules are reservoir type systems composed by an internal 
region, were the bioactive compound is incorporated, which is delimited by the coating or wall material. 
(Lesmes and McClements, 2009; Coelho et al., 2010; Zuidam and Nedovic, 2010; Nazzaro et al., 2012). 
There are different types of microcapsules, depending on the physicochemical properties of the 
bioactive compounds, the composition of the wall material and the technique used to encapsulate 
(Figure 1: B-E). They may present more than one wall with different chemical and physical properties, 
may exhibit irregular shapes and be composed of one or more core compounds (Gharsallaoui et al., 
2007).  
Chapter 2.  Literature Review                                        FucoPol as encapsulating matrix of bioactive compounds 
__________________________________________________________________________________________ 
5 
 
 
 
Figure 1 - Morphology of different types of microencapsulation: A – microspheres, B – microcapsule, C – multi-wall microcapsule, 
D – irregular microcapsule and E – multi-core microcapsule (Adapted from Gharsallaoui et al., 2007). 
 
The encapsulation has been used in many applications over the years, such as in pharmaceuticals, 
food products, fertilizers, chemicals and cosmetics (Champagne and Fustier, 2007; Sri et al., 2012).  
The advantage of producing microparticles for the food industry is due to a diversity of reasons, such 
as: (i) controlled release of the encapsulated materials at a specific time and place in the human body, 
(ii) protection of the bioactives against degradation reactions, promoted by the external factores (e.g. 
oxygen, light, humidity, heat, acids and bases, among others), (iii) masking negative organoleptic 
properties such as color, flavor and odor of the encapsulated material, (iv) stabilizing the ingredients in 
order to impose the stability of the product during the storage and/or increase its bioactivity (e.g. in the 
case of loss of vitamins, minerals, proteins and salts), (v) easily handle bioactive compounds that may 
be in another physical state (e.g. convert a liquid active compound in a powder), (vi) prevent evaporation 
and degradation of volatile active compounds such as aroma or essential oils, and (vii) immobilize the 
bioactive compounds in the food processing systems (I Ré, 1998; Anal and Singh, 2007; Gharsallaoui 
et al., 2007; Zuidam and Nedovic, 2010; Nedovic et al., 2011; Sri et al., 2012; Estevinho et al., 2013). 
Encapsulates should be produce so they do not have an adverse impact on the properties of food in 
which they are introduced, while being able to protect the encapsulated material during processing, 
storage and transportation and deliver in the intestinal tract (Vos et al., 2009). Summarizing, the 
encapsulation process is potentially a good strategy for any material that needs to be protect, isolated 
and delivered in a controlled way.  
Gouin (2004), discussed the application of the microencapsulation in the food industry and the costs 
associated with this process. This author demonstrated the increased number of scientific articles and 
patents related to new materials for use in the microencapsulation of food ingredients as well as the new 
microencapsulation techniques applied. However, many of the matrices studied don’t have applicability 
in the food industry due to their high cost and difficulties to process at an industrial scale.  
 
2.2. Bioactive compounds 
As mentioned above there are numerous bioactive compounds that may benefit with the 
encapsulation process. Phenolic compounds are examples of bioactive compounds that have recently 
increased interest in functional foods, especially because they exhibit high antioxidant activity. They are 
present in all plants, and have been identified extensively in cereals, nuts, olive oil, vegetables, fruits, 
tea and red wine (Kris-Etherton et al., 2002). Because of their antioxidant properties, these compounds 
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have health benefits such as to decrease the progression of certain cancers, to reduce the risks of 
cardiovascular diseases, diabetes, among others. However, their bioactivity is lost very easily due to 
their instability under conditions encountered in food processing and storage (oxygen, light or 
temperature) or in the gastrointestinal tract (pH and enzymes). In that way, encapsulation of phenolic 
compounds is a good strategy to maintain their stability and bioactivity, as well to mask some 
undesirable flavors and tastes (Fang and Bhanari, 2010).  
A well know phenolic compound is gallic acid (3,4,5-trihydroxicbenzoic acid) with chemical formula 
C6H2(OH)3COOH, found abundantly in tea, grapes, berries and other fruits as well as in wine. It is 
commonly used as a standard for determining the phenol content of various foods (Verma et al., 2013). 
Several substances have been applied successfully as wall materials for the encapsulation of gallic acid 
and others phenolic compounds, as described in Table 1. 
Table 1 – Wall materials used in the encapsulation of specific phenolic compounds 
Bioactive compound Wall materials References 
Olive-leaf extract Chitosan Kosaraju et al., 2006 
Anthocyanins Maltodextrin Ersus and Yurdagel, 2007 
Revestrol Chitosan 
Pectin 
Das et al., 2010 
Davidov-Pardo and McClements, 2014 
Gallic acid Mucilage from Opuntia ficus indica Medina-Torres et al., 2013 
 
Essential oils are mixtures of hydrophobic substances, namely hydrocarbons (monoterpenes, 
sequiterpene hydrocarbons, among others). They are volatile, and easily evaporate or decompose 
(Hosseini et al., 2013; Teixeira et al., 2013). These bioactive compounds present two important 
functions: health promoting and food preservative, as they present antioxidant and antimicrobial 
properties.  
Oregano essential oil is an example. Its bioactive properties are related to the presence of carvacrol 
and thymol in its composition (Beirão-da-Costa et al., 2013). The encapsulation process has been 
studied in order to improve the stability of these bioactive compounds during processing and storage. 
Beirão-da-Costa et al. (2012) studied the effect of different matrices, such as rice starch, gelatin/sucrose 
and inulin, in the encapsulation and delivery of microencapsulated oregano essential oil by spray drying.  
The high stability of bioactive compounds within biopolymer matrices, their good efficiency and 
bioavailability suggest that these may be good candidates for the fabrication of delivery systems suitable 
for use in food industry (Davidov-Pardo and McClements, 2014). 
Living microorganisms, such as probiotics, can also be encapsulated. They must be kept alive during 
processing and storage, and should be released in the gastrointestinal tract (Champagne and Fustier, 
2007). These microbial cultures, particularly found in dairy products, reinforce the natural defense 
mechanisms of the human body, since these cultures are protected from bacteriophage and harsh 
environments, such as freezing and gastric solutions (Anal and Singh, 2007). 
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Another class of encapsulated active substances are enzymes. As an example, Rodriguez-Nogales 
and Degadillo (2005), encapsulated the β-galactosidase enzyme used to hydrolyze the lactose in 
glucose and galactose, in a matrix composed by lipid molecules. If this enzyme were not encapsulated 
but incorporated into dairies in free form, it would cause organoleptic changes in the product leading to 
the rejection by consumers, as well as to its degradation before reaching the specific local of action. 
Thus, the encapsulated β-galactosidase has become an alternative to hydrolyze the lactose in glucose 
and galactose, without affecting the sensory acceptance of the lactose intolerant consumers.  
For incorporating the bioactive compounds in the matrix material, a mixture of these two components 
should be prepared. This may consist of a solution, an emulsion, a suspension of solids or a suspension 
of small microparticles (Gharsallaoui et al., 2007). 
In order to proceed with the encapsulation process with success, a special attention must be driven 
to the selection of the wall material, taking into account the core material to be encapsulated, the 
application of the produced capsules and the process used for encapsulation (Dziezak, 1988). 
 
2.3. Encapsulation wall materials  
There are many materials available and suitable for the encapsulation process. However, since they 
will be used in the food industry, these matrices must be generally recognized as safe (GRAS). So, they 
should present a chemical composition compatible with human metabolism and prior approval of the 
competent entities to be used in products for human consumption, reducing thus the number of suitable 
materials (Nedovic et al., 2011; Nazarro et al., 2012). 
In addition, the matrix should be selected according to the intended use and must be based on 
physical and chemical characteristics of the bioactive compound and according to the selected 
microencapsulation method (Wilson and Shah, 2007; Brasileiro, 2011; Estevinho et al., 2013). The 
material used as encapsulating matrix should: (i) have a low viscosity at high concentrations; (ii) present 
high water solubility; (iii) exhibit good emulsifying properties and film forming; (iv) be easy to handle 
during the encapsulation process; (v) have low hygroscopicity to prevent agglomeration; (vi) be 
compatible with the compounds to be encapsulated (must not react with the active compound); (vii) have 
a good ability to maintain the compound inside; (viii) protect the compound from adverse conditions of 
the outside environment; (ix) be neutral in flavor or present desirable organoleptic properties when 
administered orally; and (x) be economical and stable (Santos et al., 2000; Loksuwan, 2007; Carvalho, 
2009; Estevinho et al., 2013). 
The encapsulating matrices can be composed by many materials, such as carbohydrates, lipids, and 
proteins, as shown in Table 2 (Loksuwan, 2007; Gharsallaoui et al., 2007). The matrices used in the 
encapsulation process can form different shapes (capsules, spheres or irregular particles), internal 
morphologies (porous or compact) and physical structures (amorphous, crystalline, rubber or glass) 
(Madene et al., 2006). In addition, since a matrix material alone may not have all the desired features, 
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the combination of various materials may be used, favoring the encapsulation and/or the subsequent 
release (Wilson and Shah, 2007; Favaro-Trindade et al., 2010). 
Table 2 - Summary of typical wall materials used in food industries (adapted from Shahidi and Han, 1993; Barbosa-Cánovas 
et al., 2005). 
Wall materials Examples 
Carbohydrates 
Corn syrup, dextrins (malto and cyclodextrins), starch, sucrose, inulin, 
cellulose, gums (agar, gum arabic, sodium alginate, carrageenan) 
Lipids Beeswax, fats, oils, paraffin, monoglycerides 
Proteins Albumin, casein, gelatin, gluten, peptides 
 
When the encapsulates are intended to incorporate in food products, the composition of the matrix 
determines how it responds to specific environmental conditions (e.g. pH, temperature and enzyme 
activity) and interacts with other components in the food product. It is important to select matrix 
components that do not cause undesirable interactions with the final food product (Lesmes and 
McClements, 2009).  
When the bioactive compound is targeted to its release after ingestion, it is necessary to take into 
account the ability of the capsules to resist to mechanical stresses and enzymatic reactions in the mouth, 
as well as to the mechanical stresses, low pH and enzymatic reactions in the stomach. Furthermore, it 
is necessary to study the behaviour of the encapsulates when subjected to the intestine conditions (e.g. 
pH). The encapsulate properties should be designed to protect the bioactives when necessary, and to 
enable their release at the desired rate in a specific local of the gastrointestinal tract (Vos et al., 2009). 
 
2.3.1. Polysaccharides as encapsulating matrices 
Among all the mentioned materials that can be used as encapsulating matrices, polysaccharides are 
the most used for this purpose, mainly because of their versatility and variety (Nedovic et al., 2011).   
Polysaccharides are the most abundant biopolymers in nature, which can be extracted from plants 
(e.g. pectin and starch), algae (e.g. alginate, carrageenan and agar), animals (e.g. chitosan) or produced 
by microorganisms (e.g. xanthan gum, gellan and dextran). They are biodegradable and have a high 
molecular weight from 104 to 108. They may be constituted by a single (homopolysaccharides) or 
different (heteropolysaccharides) types of monosaccharides linked by gycosidic bonds, showing 
differences depending on their composition and structure (Stephen et al., 2006). The molecules of 
polysaccharides may be linear or branched and, depending on the degree of branching, changes in the 
rheological properties are observed (Stephen et al., 2006).  
The interest in natural polysaccharides have grown over the years, being applied in high value 
markets, such as food industry, pharmaceutical, cosmetic, biomedical, among others. This fact is mainly 
due to their physical and chemical properties, particularly the propensity to retain water, their rheological 
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properties, and their functionality as stabilizers, jellying agents, thickeners, emulsifiers and flocculants. 
Even when they are present at low concentrations (less than 1%) the polysaccharides have a significant 
influence on the mentioned properties (Freitas et al., 2008; Elnashar, 2011; Torres, 2012). All of these 
properties join the ease of processing the polysaccharides in various forms (films, particles, capsules, 
etc.) (Coimbra, 2010). 
 
2.3.2. Microbial polysaccharides 
Microbial polysaccharides can be divided into three main groups according to their location in the 
cell: lipopolysaccharides (LPS), presented as cell wall constituents (e.g. chitin), capsular 
polysaccharides (CPS), which form a capsule associated to the cell surface (e.g. glycogen) or 
exopolysaccharides (EPS), weakly bound to the cell surface and secreted into the extracellular medium 
(e.g. xanthan, gellan, dextran) (Sutherland, 1998; Boels et al., 2001). The EPS have easier extraction 
processes, which becomes an advantage in comparison with other natural polysaccharides, like the 
case of plants or algae (Torres et al., 2011). 
Heteropolysaccharides comprise the majority of bacterial EPS, being hydrophilic and high molecular 
weight polymers. They are typically composed of monomers like neutral sugars (e.g. rhamnose, glucose, 
galactose, mannose and fucose), uronic acids (e.g. glucuronic acid and galactoronic acid) or amino 
sugars (e.g. sugar N-acetylamino), and they usually also contain acyl groups (e.g. acetyl, pyruvate and 
sucianate). The most common sugars found in the structure of EPS are glucose and galactose, but 
some EPS have added value due to the presence of rare sugars in nature, such as fucose (Sutherland, 
1994). Most of microbial EPS are comprised by repeating units of various sizes and degrees of 
branching, which leads to a high range of molecular structures. This diversity is also related with the 
possible increase of different glycosidic linkages and configurations (Freitas et al., 2011). In addition to 
the production conditions, the chemical structure, the chemical composition and the physicochemical 
and rheological properties of the final product are also dependent on the species of microorganisms 
(Öner, 2013).  
The production of polysaccharides from microorganisms is lower compared to polysaccharides 
obtained from plants and algae, since they have high production costs, mainly due to the use of 
expensive substrates with high purity (e.g. glucose, starch and sucrose). However, their interest in the 
industrial applications has been increasing due to their unique properties and the easy manipulation of 
fermentation conditions in order to obtain new polymers with improved characteristics (Öner, 2013; 
Bastos, 2013). Moreover, the polysaccharides from algae, plants and animals have life cycles of months 
or years, with a seasonal cycle of production, and are influenced by climate changes such as solar 
energy, and environmental impacts such as pollution, which causes large variations in the quantity and 
quality of the final product. This does not happen with microbial polymers, because their production is 
continuous, with controlled operating conditions independent of external factors (Torres, 2012).   
Thus, for a new microbial polysaccharide to have success in the market it is essential to reduce its 
costs and increase its profitability. It can be done by using low cost substrates, increasing the yield of 
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the final product through the optimization of the fermentation conditions, the development of high yield 
strains (e.g. mutagenesis or genetic manipulation) and optimization of the downstream process (Freitas 
et al., 2011).  
 
2.3.3. FucoPol 
FucoPol is a new exopolysaccharide produced by the bacterial strain Enterobacter A47 DSM 23139, 
belonging to the family of Gram-negative bacteria. It is cultivated using glycerol-byproduct from the 
biodiesel industry, as the sole carbon source. This fact is one of the main advantages of this biopolymer, 
since the glycerol byproduct is available at large quantities at a low cost, due to the increase of biodiesel 
production (Cruz et al., 2011; Torres, 2012). This advantage allows obtaining a polymer at a lower cost, 
by reducing the costs associated with the substrate source. In addition, there is the conversion of a by-
product with negative environment impact, which needs to be treated, into an added value product. 
Torres (2012), characterized this new biopolymer regarding its chemical composition. It consists on 
an extracellular anionic polysaccharide of high molecular weight (~5.0 x 106), composed by fucose (32-
36 %mol), galactose (25-26 %mol), glucose (28-34 %mol), glucuronic acid (9-10 %mol) and acyl 
substituents, particularly acetate (3-5 wt.%), pyruvate (13-14 wt.%) and succinate (3 wt.%). The 
presence of the acyl groups (pyruvate and succinate) gives the polymer an anionic character, and can 
promote interactions with ions or other macromolecules (Freitas et al. 2011). Proteins (<5 wt.%) were 
also found in the composition of the FucoPol. They are present as remnants of the cultivation broth. 
Because of their high molecular weight, they are not removed in the dialysis (step of purification of the 
biopolymer).  
FucoPol has a high value in the market due to its high content of fucose, since it is a rare sugar, 
difficult to obtain, thus being available at low quantities and at a high price. In addition, fucose containing 
polysaccharides are referred to present interesting properties for the cosmetic and pharmaceutical 
industries, such as anti-cancer properties, anti-inflammatory and anti-aging properties, as well as 
positive effects on diabetes prevention (Saari et al., 2009).  
The FucoPol production is carried out in a stirred bioreactor, under conditions of controlled pH and 
temperature at 6.80 ± 0.05 and 30.0 ± 0.1 °C, respectively. The bioreactor works on the first day of 
cultivation in batch mode, where bacteria grows exponentially, while in the remaining hours (48 hours) 
it is operated in feed-batch mode in which all nutrients are continuously fed (including the glycerol 
byproduct and the nitrogen source). The synthesis of FucoPol occurs either during the batch or the fed-
batch operating modes (Torres, 2012). 
The composition and amount of FucoPol produced is highly influenced by the fermentation 
parameters, particularly pH, temperature, concentration of oxygen, agitation and the composition of the 
culture medium, with an impact on the economic viability of the process (Öner, 2013). Torres (2012), 
tested the impact of temperature and pH on cell growth and production of FucoPol, in which the results 
showed that the Enterobacter bacterium has the ability to synthesize different heteropolysaccharides 
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with different sugar composition and molecular weight as a result of modification of these cultivation 
conditions. These features allows, depending on the desired application, explore the production of 
FucoPol to obtain polymers with different compositions. This author also studied the content of fucose 
in the different polymers extracted, concluding that the portion of this sugar keeps stable when changing 
the pH and temperature, which is advantageous for the production at an industrial level.  
From studies by Freitas et al. (2010), FucoPol exhibits properties that envisage a good potential to 
be used as wall material in encapsulation process, namely its ability to produce stand-alone films 
(Ferreira et al., 2014). In addition, FucoPol forms viscous aqueous solutions with a shear thinning 
behavior. This behaviour as well as its viscosity were maintained over an extended range of pH and 
ionic strength (3.5 – 8.0 and 0.05-0.50 M NaCl, respectively). It was also found that solutions of FucoPol 
demonstrate good thermal stability when subjected to oscillations of temperature, since this biopolymer 
retained its apparent viscosity and viscoelastic properties at 25 C, after successive heating (up to 80 
C) and cooling cycles.  
These authors demonstrated that FucoPol shows the ability to form and stabilize emulsions of 
hydrophobic compounds in water, indicating good potential for various compounds, particularly for 
edible oils (emulsion index E24>60%), comparable to other commercial polysaccharides, such as 
xanthan gum and pectin. This fact is particularly important for the encapsulation of hydrophobic 
substances using FucoPol as wall material. All these properties of this new biopolymer demonstrate its 
versatility that allows its use in numerous applications.  
 
2.4. Encapsulation techniques 
There is not one universal technique for performing the encapsulation, since each compound (the 
matrix or the active compound) has its own physical and chemical characteristics. The selection of the 
more suitable technique should take into consideration, in addition to the physicochemical properties of 
both compounds, the production conditions used to define the properties of the formed microparticles, 
the conditions of release and the desired properties of the final product. Ideally the microencapsulation 
method must be simple, fast, and easy to reproduce at an industrial scale and at a low cost (Yang et al., 
2000; Brasileiro, 2011; Medeiros, 2013). 
The most common techniques can be divided into chemical process (e.g. coacervation, molecular 
inclusion in cyclodextrins), and mechanical processes (e.g. spray drying, fluid bed coating, spray 
cooling/spray chilling, extrusion, emulsification and freeze drying). Furthermore, more costly 
technologies such as liposome encapsulation are also used (Vos et al, 2009; Nedovic et al., 2011). 
Table 3 summarizes the main techniques that are used for bioactives encapsulation. 
Many of the encapsulation processes consist in a first step of dispersing the core material in a 
solution of the wall material, followed by a physicochemical process, where occurs the formation of 
particles carrying the core material (Madene et al., 2006; Zuidam and Nedovic, 2010). 
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Table 3 - Overview of common encapsulation processes (Adapted from: Madene et al., 2006; Zuidam and Nedovic, 2010) 
Technology Processe Steps 
Particle 
size (µm) 
Coacervation 
1. Introduction of three immiscible phases 
2. Deposition of the coating 
3. Solidification of the coating 
5 - 200 
Spray-drying 
1. Dispersion or dissolution of the core in a wall material 
aqueous solution 
2. Homogenization 
3. Atomization and drying 
1-100 
Fluid bed 
coating 
1. Fluidization of core particles 
2. Spray coating 
3. Dehydration or cooling 
>100 
Spray-
cooling/Spray-
chilling 
 
1. Dispersion or dissolution of the core in a  heated liquid 
solution 
2. Atomization 
3. Cooling  
20-200 
Extrusion 
1. Melting the wall material 
2. Dispersion or dissolution of the core in the molten wall 
material 
3. Extrusion  
4. Dehydration 
5. Cooling 
200-5000 
Emulsification 
 
1. Dissolution of the core and emulsifiers in water or oil phase 
2. Mixing the oil and water phases  
0.2 – 5000 
Freeze-drying 
1. Dispersion or dissolution of the core an wall materials in 
water 
2. Freezing 
3. Drying under low pressure 
4. Grinding (option) 
20 – 5000 
Liposome 
entrapment 
1. Dispersion of lipid molecules in water, with the core 
material in the lipid or water phase 
2. Size reduction by high shear or extrusion 
3. Removal of free core material (optional) 
0.1-100 
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2.4.1. Coacervation 
The coacervation consists in phase separation of one or more hydrocolloids from the initial solution, 
with the formation of two phases: one with low concentration of colloid and the other with a high 
concentration of colloid. The phase with a higher amount of colloid is in a dispersed state, which is given 
the name of coacervate. For the microencapsulation to occur, the bioactive compound is deposited 
around the newly formed coacervate phase (by suspension or emulsification), followed by solidification 
of the coacervate wall (Gouin, 2004; Barbosa-Cánovas et al., 2005).  
This technique is suitable for the encapsulation of essential oils, but can also be adapted for other 
substances, such as oils, nutrients, vitamins, among others (Gouin, 2004). Microparticles produced by 
this technique are water insoluble, heat resistant and have excellent characteristics that allow the 
occurrence of a controlled release (Burey et al., 2008; Rocha-Selmi et al., 2013).   
 
2.4.2. Fluid bed coating 
The fluid bed coating technology is restricted to the encapsulation of solid active compounds (Jyothi 
Sri.s et al., 2012). This is due to the fact that the compounds to be encapsulated are suspended in a 
fluidized bed reactor, in which flows a stream of hot air at high speed. Then, a solution containing the 
matrix molecules is sprayed at the top of the reactor, and is deposited on the surface of the solid particles 
of the active compounds (Madene et al., 2006). The capsules initiate a series of steps such as wetting 
and drying while circulating in the column of air, ending with coated dried particles. The design of the 
fluid bed reactor allows the recycling of the particles, i.e., the suspension process, spraying and cooling 
is repeated, until the microparticles are evenly coated (Jyothi Sri.s et al., 2012). 
The coating material must have certain properties to facilitate encapsulation, such as an acceptable 
viscosity in order to be able to be pumped and sprayed, must be thermally stable and should be capable 
of forming a film on the surface of the particles (Risch and Reineccius, 1995; Zuidam and Nedovic, 
2010). This technique has the advantage of being able to produce coatings of a large variety of materials 
(Gouin, 2004). 
 
2.4.3. Freeze drying 
Freeze drying or also known as lyophilisation, it is a process that relies on freezing and drying at 
reduced pressure. Firstly, the sample is frozen at temperatures between -90 C and -40 C and then it 
is dried by direct sublimation under low pressure and temperature. The major disadvantage of this 
technique is that it uses a lot of energy and needs a long processing time. In addition, the particles 
obtained may possess voids that can facilitate the loss of entrapped volatile compounds (Zuidam and 
Nedovic, 2010; Nedovic et al., 2011). 
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2.4.4. Spray-Cooling/Spray-Chilling 
A dispersion of the wall material (e.g. lipids) with the active compounds is frozen (the water doesn’t 
evaporates) and the solidification of lipids occurs, which results in the recovery of fine particles. These 
techniques are used to encapsulate solid materials that are more sensitive to heat, such as vitamins, 
minerals and proteins, since it does not involve high temperatures (Vos et al., 2009; Zuidam and 
Nedovic, 2010). The difference between the two methods is the temperature of the reactor where the 
coating material is sprayed (45 ⁰C to 122 ⁰C for the spray cooling and 32 ⁰C to 42 ⁰C for the spray 
chilling)  (Madene et al., 2006). Both techniques are able to achieve great income and may be operated 
in continuous or batch modes (Nedovic et al., 2011).  
 
2.4.5. Extrusion 
One of the encapsulation technology widely used in laboratory is the extrusion technology. It consists 
in the production of droplets by forcing the active compound, dispersed in a molten carbohydrate mass, 
to pass under pressure, through small nozzles (Vos et al.., 2009). The extruded material is immediately 
immersed in a bath of dehydrating liquid, and when it comes into contact with this liquid the coating 
matrix solidifies and entraps the active compound. Afterwards, it is dried with hot air. The size of the 
droplets depends on the diameter of the noozle, the flow rate and viscosity of the molten solution (Burey 
et al., 2008). 
The limitations of this method include its high price, the need of low solubility in cold water and the 
requirement of encapsulating compounds that allow the use of high temperatures for a long period of 
time (Barbosa-Cánovas et al., 2005). 
 
2.4.6. Emulsification 
The emulsification technique uses other means, and not only water, to perform the encapsulation 
(Burey et al., 2008). It consists in the dispersion of a liquid in a second immiscible liquid, wherein the 
first liquid includes the wall material, and the active ingredient material is included in the other one (Vos 
et al., 2009). There are several types of emulsions, e.g.: water/oil or oil/water and water/oil/water or 
oil/water/oil (Nedovic et al., 2011). 
 
2.4.7. Liposomes and Cyclodextrins 
There are other technologies that are not widely used, due to its high cost, however can serve in 
certain encapsulation. One of these cases is the encapsulation in liposomes that consists in a single or 
multi-layer membrane composed of lipid molecules, which encapsulate the active compound. These are 
formed from a dispersion of polar lipids (often phospholipids) in an aqueous solution (Vos et al., 2009). 
The hydrophilic portion is positioned to the aqueous and the hydrophobic part is associated with other 
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lipid molecules. When phospholipids are dispersed in an aqueous medium, liposomes are formed 
spontaneously (Wilson and Shah, 2007). 
Another technique is the molecular inclusion that uses a cyclodextrin molecules. These have a 
circular structure with a hydrophobic inner cavity and an exterior hydrophilic character. Hydrophobic 
bioactive molecules diffuse to the inner cavity, forming bioactive-cyclodextrin complexes. This process 
is used to increase the solubility of hydrophobic molecules and protect them from inactivation and/or 
degradation (Barbosa-Cánovas et al., 2005; Vos et al., 2009). 
 
2.4.8. Spray-drying 
The technology of spray drying is the most common technology used for encapsulation owing to its 
flexibility and continuous operation, but mainly because it is more economic comparatively with other 
methods of encapsulation. It is a complex technique mainly due to the choice of operation parameters, 
however, it is fast and has high reproducibility at laboratory or industrial scale (I Ré, 1998; Vos et al., 
2009; Zuidam and Nedovic, 2010; Nedovic et al., 2011). This process, in addition to producing 
microparticles, has several successful applications in food processing, such as dehydrating process, i.e. 
drying liquid and convert it into powder, as in the case of milk and coffee powder or fruit juices (Risch 
and Reineccius, 1995; Bhandari et al., 2013). In the case of powdered milk, the manufacture is a 
microencapsulation technique, were fat is the core of this material, being protected from oxidation by 
the mixture of lactose and milk proteins, which is the wall material (Gharsallaoui et al., 2007). 
The principle of spray drying consists in dissolving, dispersing or emulsifying the active compound in 
an aqueous solution together with the chosen encapsulating matrix and subjecting this solution to a hot 
gas atomization to obtain powder material. This technique involves the combination of several phases, 
including atomization, mixing with air, evaporation and separation of the final product.  
The choice of the atomizer is one of the important decisions to be taken into account in the spray 
drying process, since generally this selection allows to defining the size distribution of the particles 
required in the final product. There are numerous atomizers that can be used, such as pneumatic 
atomizer (two fluid nozzle), pressure nozzle, spinning disk atomizer, and sonic nozzle (Gharsallaoui et 
al., 2007). Amongst these, the pneumatic atomizer was used in the preparation of this work so it will be 
described in detail. The Figure 2 shows the structure of the spray drying apparatus used. In this 
technique the solution passes through an orifice at high pressure simultaneously with hot air. The liquid 
solution is atomized into small droplets in a hot air chamber, which promotes rapid removal of solvent 
by drying (usually water, but an organic solution may optionally be used too). A film is formed on the 
surface of droplets, resulting in a rapid solidification of the solution thereof. The denser particles are 
collected at the bottom of the drying chamber and the finer are collected in dry collectors, e.g. cyclone, 
at low temperatures to be separated from the moist air. After completing the drying, all air drying is 
directed to the atmosphere (Masters, 1983; I Ré, 1998; Burey et al., 2008; Zuidam and Nedovic, 2010). 
The hot gas that enters into the chamber can be air or an inert gas. It can be heated directly by fuel, or 
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indirectly by steam or electricity. An inert gas is used when the solvent that is necessary to remove is 
not water and can be flammable (Burey et al., 2008). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 – Scheme of the Spray drying Lab-Plant SD 05, Huddersfield 
The contact between the drying air and the sprayed droplets may be conducted in three ways: 
concurrent, countercurrent or mixed flow. In the case of the concurrent, the feed solution and the drying 
air are dried in the same direction through the drying chamber. This type of drying is most commonly 
used in heat-sensitive products, since evaporation occurs rapidly and the dried particles are exposed to 
more moderate temperatures, below the limit for thermal degradation. This type of operation is widely 
used in food products. In the case of countercurrent operation, the drying air and the particles flow in 
opposite directions in the drying chamber, and the dried product is exposed to higher temperatures, 
which limits the application for heat sensitive products (Gharsallaoui et al., 2007). The particles that are 
produced by the method of concurrent are more likely to be porous than those by countercurrent, 
exposing the encapsulated more easily to unfavorable conditions (Zuidam and Nedovic, 2010). In a mix 
flow drying, the particles move in the chamber at concurrent and countercurrent modes (Walton, 2002).    
The particles obtained by spray drying can vary its size from 1 to 100 µm or be particles with much 
higher size (2-3mm) depending on the conditions of production (Madene et al., 2006; Gharsallaoui et 
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al., 2007; Fand and Bhandari, 2010). The morphology of particles produced by spray drying can have 
three distinct categories: agglomerates, skin-forming and crystalline. Particles with an agglomerate 
structure are composed by individual grains with less than 1 µm of diameter, that are connected to each 
other, such as rich starch spherical aggregates produced by Beirão-da-Costa et al. (2011); the skin-
forming particles are composed of a continuous non-liquid phase that is polymeric or microcrystalline in 
nature and particles with a crystalline structure are particles composed of large individual crystal nuclei 
bound together by a continuous microcrystalline phase (Walton, 2002; Bhandari et al., 2013). Internally 
it is important to form hollow structures so that appropriate microencapsulation occur. The particles 
surface can also show folds, holes or fractures (King, 1984). 
The structure of the microparticles prepared by spray drying are strongly linked to the parameters of 
the operation of this method, describe in Table 4. The main factors of spray drying to be optimized are 
the following: the feed properties (core/wall material ratio, wall material concentration, viscosity an 
temperature), atomization conditions, air flow, air inlet and outlet temperature (Zuidam and Nedovic, 
2010). 
  Table 4 – Spray drying operation parameters (Adapted from Bhandari et al., 2013) 
Feed  Temperature 
 Flow rate 
 Wall material concentration 
 Core/Wall ratio 
Atomization Noozle diameter 
 Air pressure 
Inlet air flow Temperature 
 Flow rate 
 Humidity 
Outlet air flow Temperature 
 Humidity 
 
The viscosity of the solutions is usually technique limiting parameter, since high viscosity (due to 
high concentration of polymer, branched polymer, etc.) will hinder the formation of particles and lead to 
the development of large droplets that have a negative impact on the drying rate and decrease the 
retention of the active compounds, which consequently reduces the yield of this processes. In the case 
of high viscosity systems, it may be decreased by heating the feed. Yet, it is necessary to have 
precaution because high feed temperatures can cause the volatilization or the degradation of some heat 
sensitive ingredients (I Ré, 1998; Brandari et al., 1997; Gharsallaoui et al., 2007; Estevinho et al., 2013). 
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The air inlet temperature in the dryer varies normally between 150 and 220 C. A too high inlet 
temperature can result in a rather fast and excessive evaporation, resulting in the rupture of the wall, 
with the consequent premature release of the core material. On the other hand, when the temperature 
is too low, the evaporation rate is very low and may cause the formation of microparticles with high 
density wall, high water content, low fluidity and ease of agglomeration. Thus, a proper adjustment of 
air temperature and flow rate is essential since the formation of firmer wall layer particles allows greater 
retention of the active ingredient.  
The outlet air temperature depends on the inlet temperature and drying characteristics of the 
material, so it cannot be set directly. The outlet temperature for encapsulation of food ingredients 
reported in the literature varies between 50 and 80 C, which can be considered as a measure to control 
if the drying was well performed (I Ré, 1998; Gharsallaoui et al., 2007; Estevinho et al., 2013). 
Due to the complexity of the various stages of spray drying, especially the amount of different 
parameters involved in this process, the equipment tests are based on experience, trial and error and 
first working on a pilot scale (Gharsallaoui et al., 2007). 
One limitation of this process is related to the restricted number of materials that can be used as 
encapsulating matrix, since it is necessary to exhibit certain characteristics such as low viscosity at high 
concentration, emulsifying ability, film-forming capacity and have a high solubility in water. Typically this 
process uses for encapsulating, matrixes such as carbohydrates (e.g. starch, maltodextrins and Arabic 
gum) and proteins (e.g. gelatin and milk proteins) (Gouin, 2004; Estevinho et al., 2013). Another 
disadvantage of this process is the production of very fine power particles during the use of lower feed 
rates, so the particles may need further processing, such as agglomeration (Gharsallaoui et al., 2007). 
Moreover, this operation has some losses of product and the yield is not the desired due to adherence 
of particles to the interior wall of the drying chamber and cyclone (Tewes et al., 2006). 
The spray drying is an ideal process when it is desired to obtain a final product that compiles quality 
standards such as particle size, distribution, density and mass of the particle and the moisture content 
of the particles (Walton, 2002). The best conditions for spray drying are a combination between high air 
temperatures, high content of soluble solids concentration, easy spraying and drying without swelling or 
cracking in the final particles (Gharsallaoui et al., 2007). 
The technique of spray drying when compared with other methods of encapsulation has the 
advantage of lower particle size obtained, which is smaller than most of the other processes, such as 
fluid bed coating, extrusion, emulsification, freeze-drying, among others. In addition, the drying of 
products and exposure to high temperature, takes only of a few seconds. In the food industry this is an 
advantage because there are many temperature sensitive active compounds that may suffer 
undesirable changes when subject at high temperatures (I Ré, 1998; Walton, 2002).   
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2.5. Release mechanisms 
As mentioned above, the encapsulation of food ingredients (core) allows them to be protected from 
the external environment by a wall material, with the objective of being released in a desired place and 
rate (Pothakamury and Barbosa-Cánovas, 1995).  
The release of the compounds depends mainly on the characteristics of the particles, as their 
morphology, chemical composition and structure, wall thickness and pore size (when applicable), 
particles specific surface and the preparation method. The mechanism of release of the active 
compound may occur through the action of various factors, such as: temperature; humidity; pH changes; 
enzyme activity; time; osmotic force; volatility of the core; effect of solvent; diffusion; degradation or 
fracture of particles (I Ré, 1998; Bertolini et al., 2001; Gouin, 2004; Anal and Singh, 2007). 
There are main four different types of controlled release systems according to the way that the 
compounds are released: (i) by diffusion; (ii) by swelling; (iii) by osmotic pressure; (iv) by degradation. 
It is common the presence of more than one release mechanism simultaneously (Estevinho et al., 2013).   
Controlled release by diffusion: the embedded active compound can be delivered from the matrix 
through diffusion followed by transport away from the barrier surface into the environment (e.g. food 
product, gastric fluid, intestinal fluid). The transport is controlled by the solubility of the active substance 
and by the permeability of the wall material. In capsules systems, where the compound is surrounded 
by a wall membrane, the compound diffuses slowly through the membrane pores, if present, and/or 
through the dense polymeric phase. The physical state of the wall material has an important role in the 
diffusion, since matrixes with an amorphous glassy structure are considered a strong barrier for 
diffusion, while matrixes with a rubbery structure are more permeable with a higher diffusion rate of 
solutes. The proportion of crystalline material in the matrix is also important because crystalline phases 
are also barriers to diffusion, while amorphous regions consist of higher diffusion zones. In the case of 
dense particles, in which the compound is dispersed or dissolved in the matrix, the release rate is 
controlled by the rate of diffusion through the matrix (Pothakamury and Barbosa-Cánovas, 1995; Risch 
and Reinecciuns, 1995; I Ré, 1998; Coimbra, 2010).  
Controlled release by swelling: When the particles are placed in a thermodynamically compatible 
medium, the solvent is absorbed from the outside to the inside of the wall material, occurring its swelling 
and enabling the bioactive compounds release. The swelling of the particles is due to the ability of some 
of the matrix materials to absorb water without dissolving (Pothakamury and Barbosa-Cánovas, 1995; 
Coimbra, 2010). 
Controlled release by osmotic pressure: This system is very similar to swelling, since osmosis is the 
transport of water from a lower to a higher solutes concentration medium. In the case that the bioactive 
compound presents high solubility in water and is enclosed in a selective water permeable membrane, 
that is impermeable to this compound, an osmotic pressure difference is established due to the 
concentration difference between the inner liquid medium and the surroundings, leading to a flow of fluid 
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(water) from the outside to the inside of capsules, forcing the inner solution to leave the interior 
(Pothakamury and Barbosa-Cánovas, 1995). 
Controlled release by degradation: This release mechanism occurs when there is the degradation of 
the wall material with the consequent release of the encapsulated compounds. The degradation may 
occur by erosion, chemical reactions, enzyme catalysed reactions or by the action of microorganisms.  
As an example, when matrices contain proteins or lipids, the particles are degraded within the human 
body by enzymes (proteases and lipases, respectively) (Pothakamury and Barbosa-Cánovas, 1995; 
Barbosa-Cánovas et al., 2005). 
From all the systems referred, diffusion and swelling are the release mechanisms more associated 
with the microcapsules produced by spray drying (I Ré, 1998).   
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Chapter 3 – Materials and Methods 
 
This chapter includes all the experimental activity, organized into four sections central: 
I. Extraction and purification of FucoPol 
II. Rheological properties of FucoPol solutions 
III. Production of FucoPol particles by spray drying and their characterization 
IV. Encapsulation of bioactive compounds on FucoPol particles by spray drying 
In the first stage of this work, FucoPol was extracted from the fermentation broth and purified. This 
work was carried out at Faculdade de Ciências e Tecnologia da Univerdade Nova de Lisboa, were 
FucoPol was produced.  
In a second step, the viscosity of FucoPol solutions, with different biopolymer concentrations, was 
evaluated at different temperatures. This study was performed in order to select the feed conditions 
(polymer concentration and temperatures) to be used in the spray drying process.   
The third step consisted on the study of the effect of selected process parameters (FucoPol 
concentration on the feed, feed temperature and drying temperature) on the characteristics of the 
FucoPol particles obtained.    
The final part of the work consisted on the encapsulation process of two model bioactive substances, 
gallic acid (GA) and Oregano essential oil (OEO) using FucoPol as wall material.  
 
During the elaboration of this study were used three main materials, which are mentioned below. 
The other materials are specified in each method. 
 For the matrix was used the biopolymer, the FucoPol, provided by the Faculdade de Ciências e 
Tecnologia, Universidade Nova de Lisboa; 
 For the core material were used a commercial gallic acid (3,4,5 – trihydroxybenzoic acid, GA), 
purchased from Sigma-Aldrigh, and oregano essential oil (OEO), produced in Alentejo region in the 
south of Portugal. 
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3.1. Extraction and purification of FucoPol 
At the end of the cultivation of the Enterobacter for FucoPol production, mentioned in section 2.3.3, 
downstream processing is needed to extract and purify the biopolymer, since this broth contains remains 
of nutrients, metabolites and the microorganisms. The downstream processing involved the following 
steps: 
(i) Dilution of the culture broth with deionized water for viscosity reduction (1:4 v/v); 
(ii) Centrifugation (8000 rpm, 30 minutes, 4 C) for biomass removal, obtaining a cell free supernatant; 
(iii) Heat treatment (70 C during 1 hour) for deactivate unseparated cells in the previous step and for 
denaturation of external enzymes that may cause the FucoPol degradation; 
(iv) Centrifugation (8000 rpm, 40 minutes, 4 C) in order to remove cell debris and denatured proteins; 
(v) Removal of low molecular weight compounds (e.g. salts, glycerol, and nitrogen source) from the 
supernatant by dia-ultrafiltration. The dia-ultrafiltration process consists on pumping the 
supernatant through an ultrafiltration hollow fiber module with a 500 kDA cut-off and 2800 cm2 
membrane area, recirculating the retentate to the supernatant reservoir. The feed reservoir was 
maintained constant by adding deionized water at the same rate of the permeate rate. During the 
process, a regular monitoring of the ionic strength of the feed solution was performed. It was 
stopped when the conductivity decreased below 150 µScm-1, a value for which it was considered 
that most of the impurities had been removed; 
(vi) The purified supernatant was concentrated working in an ultrafiltration mode; 
(vii) The concentrated supernatant was dried at 50 C. 
 
3.2. Rheological properties of FucoPol solutions 
3.2.1. Preparation of Fucopol Aqueous Solutions  
A FucoPol solution with a concentration of 2.0 wt.% was prepared by dissolving the polymer in 
deionized water and under stirring overnight (12 hours), at room temperature, in a magnetic stirrer (ARE, 
Velp). Afterward, solutions with concentrations of 1.4 wt.%, 1.0 wt.% and 0.7 wt.% were prepared by 
dilution with deionized water.  
 
3.2.2. Viscosity Measurements  
The apparent viscosity of FucoPol aqueous solution (2.0 wt.%, 1.4 wt.%, 1.0 wt.%, and 0.7 wt.%) 
was measured all three different temperatures (20 C, 50 C, and 70 C). These tests were performed 
using a controlled stress rheometer (Haake RS 75, Germany) equipped with cone and plate geometry 
with a cone diameter of 35 mm and an angle of 2 degrees.  Each sample was placed in the rheometer 
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plate with a volume of 0.6 mL. Then the interface between the sample and the air was covered with 
liquid paraffin in order to minimize dehydration.  
The flow curves were measured using a steady state flow ramp for a shear rate range from 0.01 to 
700 s-1. Each test was performed in duplicate.  
 
 3.3. Production of FucoPol particles by spray drying 
3.3.1. Process parameters 
In order to study the production of FucoPol particles by spray drying, a factorial design with three 
independent variables (FucoPol concentration in the feed, feed temperature and inlet air temperature) 
at eight levels was applied. Taking into account the viscosity results, were used the 1 and 2 wt.% 
FucoPol concentrations and the feed temperatures of 20 and 60 ºC. The air inlet temperatures (150 and 
200 ºC) were selected according to the range of values usually referred in the literature (Gharsallaoui et 
al., 2007) for polysaccharide matrices. The factorial design (Lundstedt et al., 1998), where x1 is the 
FucoPol concentration, x2 is the feed temperature and x3 is the inlet air temperature is presented in 
Table 5.  
Table 5 – Factorial design matrix - coded and decoded values of independent variables. 
Sample X1 X2 X3 
FucoPol  
(wt.%) 
Feed 
Temperature 
(C) 
Inlet air 
Temperature 
(C) 
S1 -1 -1 -1 1 20 150 
S2 1 -1 -1 2 20 150 
S3 -1 1 -1 1 60 150 
S4 1 1 -1 2 60 150 
S5 -1 -1 1 1 20 200 
S6 1 -1 1 2 20 200 
S7 -1 1 1 1 60 200 
S8 1 1 1 2 60 200 
 
 
3.3.2. Spray drying process 
A volume of 100 mL of each FucoPol solution was prepared, by the same methodology described in 
section 3.2.1. The solutions were dried in a laboratory plant scale co-current spray drying (LabPlant SD-
05) equipped with a 0.5 mm diameter nozzle. During all the process the feed was stirred with a magnetic 
stirrer (AREX). The feed inlet flow rate was set at 3.8 mL/min and the pressure of the compressed air 
was set at 1.7 bar. The solutions were submitted to the drying parameters presented on Table 5. The 
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dried powder collected at the bottom of the cyclone was stored in eppendorf tubes properly sealed with 
parafilm and kept away from light and moisture. The yield of spray-drying was defined as follows (Su et 
al., 2008): 
Spray Drying Yield (%) = Mp / MI  x 100     (1) 
Where Mp is the mass of collected powder after spray drying and MI is the mass of FucoPol added 
in the feed solution. 
 
3.4. Encapsulation of bioactive compounds on FucoPol particles 
GA and OEO were chosen as model compounds to be used as core material for encapsulation. GA 
was selected to serve as model of phenolic compounds. These compounds, are mentioned in literature 
review (section 2.2.) as to possess well know health benefits because of their natural antioxidant 
capacity. The OEO presents also a good antioxidant capacity and antimicrobial activity, and was 
selected as a model of hydrophobic complex natural extracts. Both materials are easily degraded, and 
their stabilization can be improved by encapsulation.  
For the encapsulation of the GA and OEO the drying conditions were selected accordingly to the 
results obtained in the section 3.3.2. FucoPol concentrations of 2 wt.%, feed temperature of 20 C and 
air inlet temperature of 200 C. The feed was pumped with a peristaltic pump to the spray dried referred 
in section 3.3 (LabPlant SD-05) at a rate of 3.8 mL/min. The dried powders were collected and stored 
in eppendorfs, properly sealed with parafilm and stored away from light and moisture, until further 
analysis. 
 The preparation of the feed solutions/emulsions were prepared according to the scheme of the 
Figure 3.  
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- Feed with Gallic Acid (GA):  
Particles with GA were prepared according to a method modified from the one described by Medina-
Torres et al. (2013). Initially, GA was dissolved in distilled water. Afterwards FucoPol was added and 
the mixture was left under stirring overnight using a magnetic stirrer (AREX). At the end, a solution 
containing 2 wt.% FucoPol and a GA concentration of 15 wt.%. (FucoPol basis) was obtained. This 
solution was fed to the spryer drier. 
- Feed with Oregano Essential Oil (OEO): 
Before proceeding to the encapsulation was required extract the OEO. This oil was obtained by 
steam distillation of dry leafs of Oregano (Origanum vulgare L.) using a Clevenger-type apparatus. After 
distillation, the OEO was stored in the dark under refrigeration.  
The preparation of particles with OEO was performed according to the described by Beirão da Costa 
et al. (2012) with some adjustments (Figure 3B). Initially the FucoPol solution was prepared at a 
concentration of 2 wt.%, by dissolving the polymer in distilled water at room temperature and stirring 
overnight (12 hours) with a magnetic stirrer (AREX). Afterwards, the OEO was gradually added to the 
FucoPol solutions, at a concentration of 15 wt.% FucoPol basis. The mixture was strongly homogenized 
with an ultra-turrax homogenizer (IKA Labortechnik T25 Basic) at 9500 rpm over 1 minute, to form an 
emulsion. This emulsion was fed to the spray drier. 
Figure 3 – Scheme of production of particles with (A) GA and (B) OEO 
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3.5. Particles characterization 
The characterization of the particles, with and without bioactive compounds, was carried out at 
CENIMAT, in Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa.  
 
3.5.1. Particles morphology  
The particles morphology was analysed by Scanning Electron Microscopy (SEM) and Confocal 
microscopy. 
SEM observations were carried out using a Carl Zeiss AURIGA CrossBeam (FIB-SEM) workstation, 
equipped with EDS (Energy Dispersive X-ray Spectrometry). The particles cross section was observed 
using FIB with Ga+ ions accelerated with 30 kV at 100 pA. A thin layer (~30 nm) of carbon was deposited 
on the surface to minimize Ga contamination and avoid possible surface damage. The etch rate was 
714 nm/min.  
Confocal microscopy was performed using a Zeiss LSM 700 Laser Confocal Microscope with a 100X 
objective and a pinhole size of 1 Airy Unit. The sample was excited using the 488-nm laser beam and 
observed through a prism filter set at a bandwidth of 500-700 nm. Three-dimensional reconstruction 
was performed using the ZEN 2011 software package.  
 
3.5.2. Crystallinity and chemical analysis 
The crystallinity analysis was carried out by X-Ray Diffraction (XRD) using a PANalytical X’Pert PRO 
diffractometer, equipped with an X’Celerator detector, in a BraggBrentano geometry with Cu K line 
radiation ( = 1.5406 Å). The 2θ scans were performed from 10 to 90, with a step size of 0.033.  
Fourier Transform Infrared (FTIR) data were recorded using an Attenuated Total Reflectance (ATR) 
sampling accessory (Smart iTR) equipped with a single bounce diamond crystal on a Thermo-Nicolet 
6700 spectrometer. The spectra were acquired with a 45⁰ incident angle in the range of 4500-525 cm-1 
and with a 4 cm-1 resolution.   
 
3.5.3. Thermal analysis 
Thermogravimetric measurements were carried out using a Simultaneous Thermal Analyser (TGA-
DSC-STA 449 F3 Jupiter from Netzsch). Approximately 2 mg of each sample was loaded into an open 
Al crucible and heated from room temperature to 550 C with a heating rate of 5 ⁰C min-1, in air.  
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3.5.4. Efficiency of encapsulation (EE) and particles loading with encapsulated 
bioactives 
To calculate the bioactives (GA and OEO) loading of the particles with encapsulated compounds, 
the method described by Rocha et al. (2012), was used, with some modifications. The bioactive 
compound contents of the microparticles was extracted by contacting a mass of 25 mg of each 
microparticles with 50 mL of methanol (MeOH, Sigma Aldrich). The suspension was strongly 
homogenized with an ultra-turrax homogenizer (IKA Labortechnik T25 Basic) at 13500 rpm during 3 
minutes, in order to break the particles. After mixing, the suspension was left in the dark for 12 hours at 
low temperatures (10 ºC). Then, the suspension was centrifuged (HERMLE Labortechnik Z 383 K) 
during 15 minutes at 10000 rpm and 4 C. 
In order to be possible calculate the GA and OEO concentration present in the particles, the 
absorbance of the supernatant solutions was measured (UNICAM, UV/Vis Spectrometer – UV4) at a 
wavelength of 280 nm, after suitable dilutions. 
Standard curves were prepared. These curves, presented in Appendix I, were performed with GA in 
methanol with concentrations from 2.5 mg/L to 17.5 mg/L and solutions with OEO in methanol with 
concentrations from 25 mg/L to 175 mg/L. The particles loading were expressed as the mass of GA and 
OEO per mass of particles.  
The efficiency of encapsulation (EE%) was determined as described by Rocha et al. (2012), with 
some alterations. After knowing the bioactives loading of the particles, the EE was calculated as the 
ratio between the overall mass of bioactive compounds present in the FucoPol particles collected and 
the bioactives mass initially present in the feed.  
 
3.6. Release studies 
The goal of these delivery studies was to simulate the release from the microparticles in a specific 
location in the human gastrointestinal (GI) tract. However, the results of in vitro digestion models do not 
correspond exactly to what happens in in vivo models due to difficulties in accurately simulate the 
complexity of the human digestive tract (Hur et al., 2011). 
 
3.6.1. Preparation of standard simulated fluids  
Encapsulates were subjected to two fluids, in order to simulate the stomach and small intestine 
conditions. The preparation of standard simulated fluids was similar to the one described in the United 
States Pharmacopeia, but without enzymes.   
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- The Simulated Gastric Fluid (SGF) without pepsin was prepared by dissolving 20g of sodium 
chloride (NaCl – Sigma Aldrich) in 70 mL of hydrochloric acid (HCl – Sigma Aldrich) and completed with 
sufficient water to make 1000 mL. Then the pH was adjusted to 1.2  0.1, either with 0.2 N sodium 
hydroxide (NaOH – Sigma Aldrich) or 0.2 N HCl. 
 
- The Simulated Intestinal Fluid (SIF) without pancreatin was prepared by dissolving 6.8 g of 
monobasic potassium phosphate (KH2PO4 – Sigma Aldrich) in 250 mL of water, and adding 77 mL of 
0.2 N sodium hydroxide (NaOH). Then, the solution was diluted with water to a final volume of 1000 mL, 
and adjusted to obtain a pH of 6.8  0.1 with either 0.2 N NaOH or 0.2 N HCl.  
 
3.6.2. Release assays 
The release studies were carried out in a water jacketed glass vessel, under constant stirring (ARE, 
Velp). The temperature was controlled at 37C, with a water bath. 
In each release assay, 50 mg of particles (FucoPol with GA or FucoPol with OEO) were suspended 
in 50 mL of simulated fluid (SGF – pH 1.2 or SIF – pH 6.8). After the slowly addition of the particles on 
the solution, in order to not create agglomerations, 1 mL of solution was taken out at specific time 
intervals and centrifuged (Thermo Scientific) during 1 minute at 1000 rpm. The supernatant was stored 
in Eppendorf tubes for subsequent analysis by spectrometry. By each sample that was taken, 1 mL of 
fresh medium was used to remove the pellet, being both added into the release medium, in order to 
maintain constant the volume and the mass of particles over time.    
For the in vitro digestion models, depending on the food where the microparticles are added, the 
human digestion time is about 1-2 hours (Hur et al., 2011). Thus, each assay lasted about 380 minutes, 
in order to simulate all digestion time, and was conducted in a dark room.  
 The concentration of GA and OEO in the release medium was analyzed by spectrophotometry 
(Unicam, UV/Vis Spectrometer – UV4) at a wavelength of 280 nm. To quantify the GA and OEO in the 
release medium, it was necessary prepare calibration curves of each compound in both media (SGF 
and SIF), which are presented in Appendix II. For GA, the concentration range of the calibration curve 
was 0 – 20 mg/L in SGF, and 0 – 50 mg/L in SIF medium. For OEO in SGF medium, was carried out a 
calibration curve with concentrations in the range of 0 – 420 mg/L and in SIF medium, in the range of 0 
– 550 mg/L.  
 
3.6.3. Optical microscopy  
The microparticles with bioactive compounds were observed using an optical microscope (F-view 
soft image system, Olympus BX51), with the purpose to verify the physical integrity of the particles in 
specific moments of the release assays.  
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A drop of the release medium (SGF or SIF) with the particles were placed in microscope slides, and 
covered by a cover slip. The best resolution of the samples was achieved with the 1000x objective lens. 
The optical test consisted to observe the particles in each medium, after 5 minutes and 60 minutes 
under stirring. 
 
3.7. Determination of antioxidant activity of the model compounds 
before and after encapsulation 
Since the two model compounds (GA and OEO) are recognized for their antioxidant activity, two 
different methods (DPPH and FRAP) were used to measure it, before and after the encapsulation 
process.  
3.7.1. DPPH method 
This method evaluates the antioxidant capacity of the compounds according to the reduction of free 
radical 2,2–diphenyl-1-picrylhydrazyl (DPPH). This radical has an absorption band in the range of 515-
520 nm, which disappears upon reduction by an antioxidant compound (Brand-Williams et al., 1995). 
So, the higher the antioxidant capaciity of the sample, the higher amount of radical will be consumed. 
Consequently, a higher decrease of its absorbance is observed, after reaction. The DPPH produces a 
purple solution in methanol that changes to a yellowish coloration when the radical reacts with the 
antioxidant, being possible to determine the antioxidant activity by spectrophotometry (Carmona-
Jiménez et al., 2014).  
The DPPH assay was determined according to the method reported by Thaipong et al. (2006) with 
some modifications. Initially, a stock solution was prepared by dissolving 24 mg of the DPPH (Sigma 
Aldrich) in a volumetric flask of 100 mL, completing the remaining volume with methanol. Then, the 
solution was mixed and stored in a freezer at least 2 hours before use. This solution can be stored for a 
period of 5 days.  
After this time, a working solution was prepared by mixing 10 mL of the stock solution with 45 mL of 
methanol in an amber glass, in order to obtain an absorbance lower than 1.1 units at 517 nm. If the 
solution doesn’t present an absorbance in this range, it is necessary to dilute with methanol until it 
reaches the desired value.  
To measure the antioxidant activity of GA before the encapsulation, a solution (C=40 mg/L) with 
methanol was prepared. In the case of the OEO, the concentration of the solution was 430mg/L. To 
measure the antioxidant activity after encapsulation, the methanolic extracts obtained in section 3.5.4 
were used. 
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For all samples an aliquot of 150 µL was added to 4 mL of the working solution in an amber glass, 
and let to react during 40 minutes in the dark and at room temperature. Then, all absorbances were 
read in the spectrophotometer (Unicam, UV/Vis Spectrometer – UV4) at a wavelength of 517 nm. In 
addition to the solutions (matrix + radical), a reference solution with 150 µL of methanol and 4 mL of 
work solution was also prepared as blank (radical). The measurements were performed in triplicate. 
From these values of absorbance, the Radical Scavenging Activity (RSA) was measured, expressed 
in percentage, Eq. (2):  
            RSA (%) = 
(𝐴𝑏𝑠𝑟𝑎𝑑𝑖𝑐𝑎𝑙− 𝐴𝑏𝑠𝑠𝑎𝑚𝑝𝑙𝑒)
𝐴𝑏𝑠𝑟𝑎𝑑𝑖𝑐𝑎𝑙
  X 100        (2) 
A calibration curve using Trolox (Sigma Aldrich) as standard was prepared, in order to convert the 
values of RSA to Trolox (M). To perform this curve, Trolox solutions with 50 µM, 100 µM, 200 µM, 300 
µM, 400 µM, 500 µM, 600 µM and 800 µM were prepared, which were made to react with the DPPH 
radical in the same conditions as the samples. The straight line obtained is presented in Appendix III. 
The final results of antioxidant activity of the compounds are expressed as Trolox Equivalent 
Antioxidant Capacity (TEAC) Eq. (3), defined as the antioxidant capacity of the sample, relative to one 
micromole basis of Trolox (Berg et al., 1999). Thus, as higher the TEAC value, higher is the sample’s 
antioxidant activity.  
 
TEAC = Trolox (µmol) / g of bioactive     (3) 
 
3.7.2. FRAP method 
FRAP (Ferric-reducing antioxidant power) is a method with the same aim as the previous one, 
however it is based on the reduction of a ferric-tripyridyltriazine complex (Fe3+ – TPTZ) to its ferrous 
form (Fe2+- TPTZ), which form an intense blue color at 595 nm (Gil et al., 2002). Consequently, the 
higher the antioxidant power of the compound, the more intense becomes the solution’s color.  
The FRAP assay was done according to Thaipong et al. (2006) with some modifications. Firstly, 
three stock solutions were prepared: 
 0.3 M acetate buffer - dissolving 1.6 g of C2H3NaO2 (Sigma Aldrich) in 8 mL of C2H4O2 (Sigma 
Aldrich) and complete the volume (500 mL) with deionized water. It was stored in an amber glass at 
room temperature; 
 0.01 M TPTZ (2,4,6-Tris(2-pyridyl)-s-triazine) - dissolving 1.56 g of TPTZ (Sigma Aldrich) in HCl  
0.04 M (Sigma Aldrich) to complete the volume (500 mL). It was stored in an amber glass at refrigerated 
temperature; 
 0.02 M FeCl3.6H2O – dissolving 2.7 g of FeCl3 (Sigma Aldrich) and complete the volume (500 mL) 
with deionized water, and storing in an amber glass at refrigerated temperature. 
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 From these stock solutions, the working solution of FRAP reagent was prepared by mixing 25 mL of 
the acetate buffer, 2.5 mL of TPTZ solution and 2.5 mL of the FeCl3.6H2O solution.  
 To measure the antioxidant activity, 90 µL of each sample were placed in test tubes to react with 270 
µL of deionized water and 2.7 mL of the working solution (FRAP). In parallel, a reference was analyzed 
by adding 90 µL of deionized water instead of a sample. Then, all the tubes were homogenized and 
placed in a water bath during 30 minutes at 37 C. After this time, the absorbances were measured in 
the spectrophotometer (Unicam, UV/Vis Spectrometer – UV4) at a wavelength of 595 nm. 
In simultaneous two standards curves were performed, using Trolox (Sigma Aldrich) and iron sulfate 
(Sigma Aldrich), as reference antioxidants (Appendix IV). In the case of Trolox, solutions with 50 µM, 
100 µM, 200 µM and 300 µM, were prepared. Iron sulfate solutions were prepared with 50 µM, 1000 
µM, 1500 µM and 2000 µM.  
The antioxidant activity of the compounds was expressed as Trolox Equivalent Antioxidant Capacity 
(TEAC) Eq. (3) and as Iron Sulfate µmol / g of bioactive. 
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Chapter 4 – Results and Discussion 
 
4.1. Viscosity of purified FucoPol solutions at different 
concentrations and temperatures 
The apparent viscosity of FucoPol solutions at concentrations of 0.7 wt.%, 1.0 wt.%, 1.4 wt.%, 2.0 
wt.% was evaluated at different temperatures (20 C, 50 C and 70 C), allowing to obtain the flow 
curves represented in Figure 4.   
Figure 4 - Flow curves of FucoPol solutions at different concentrations (A) 0.7 wt. %, (B) 1 wt. %, (C) 1.4 wt. % and (D) 2.0 wt. %; 
and temperatures: () 20C, () 50C and (▲) 70C; The lines represent the predictions of the Cross model.  
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For all tested solutions, it is observed that when the shear rate is low, a Newtonian plateau is 
established or approached, in which the viscosity presents a higher value, followed by a reduction of the 
viscosity that results from the increase of the shear rate, showing a shear-thinning behavior.  
The behavior of these samples can be explained by changes in the molecules organization, when 
the shear rate changes. The FucoPol molecules have structures able to create interactions in the 
solution (e.g. entanglements and hydrogen, electrostatic and hydrophobic bonds). The incidence of 
energy to the solutions influences the formation or breaking of such interactions (Cruz et al., 2011). 
Thus, at low shear rates the breaking of entanglements by the forced shear is equal to the formation of 
new ones and no changes are reflected, occurring the Newtonian plateau when the viscosity presents 
a constant value, the zero shear rate apparent viscosity (0). For high shear rates, the rate of disruption 
of entanglements predominates in relation to the rate of formation of new ones, occurring a partial 
alignment of the molecules that leads to a decrease of the apparent viscosity with the increase of the 
shear rate. As result occurs the transition from Newtonian to shear-thinning behavior (Sittikijyothin and 
Gonçalves, 2005), as shown in Figure 4. 
The lower the polymer’s concentration in the solution, the lower the viscosity This fact is due to the 
reduction of the amount of macromolecules in solution, thereby reducing the number of interactions 
between the polymer chains. In addition, the transition from the Newtonian plateau to the shear thinning 
region moves to higher shear rate values. 
As shown in Figure 4, in all concentrations the apparent viscosity decreases with the temperature 
increase, which shows the influence of the temperature on the polymer’s rheological properties. 
Nevertheless, the shear-thinning behavior was maintained even for the highest temperature test (70 
C). Cruz et al. (2011), have studied the effect of temperature and have shown that subjecting FucoPol 
solutions to consecutive fluctuations of temperature (up to 80 ºC) does not affect its rheological 
properties at 25 ºC. This allows to conclude that this new biopolymer produces aqueous solutions that 
are thermorheologically stable and could be used in processes where thermal variation can occur (e.g. 
food processing). 
The Cross model Eq. (4) was fitted to the shear-thinning behavior of the FucoPol solutions at different 
temperatures:  
𝜂𝑎  = 𝜂∞ + 
(𝜂0− 𝜂∞)
[1+(𝜆?̇?)𝑚 ]
          (4) 
where ?̇? is the shear rate (s-1), 𝜂𝑎 is the apparent viscosity (Pa.s), 𝜂0 is the zero-shear rate viscosity at 
first Newtonian plateau (Pa.s),  (s) is a time constant, 𝜂∞ is the infinite shear rate viscosity at second 
Newtonian plateau (Pa.s) and m is a dimensionless constant associated to the power-law index (n) by 
m=1-n, where n  is the flow index. Since the second Newtonian plateau was never approached in our 
study, the Eq. (6) was simplified assuming 𝜂𝑎 ≫ 𝜂∞ and 𝜂0 ≫ 𝜂∞.  
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To adjust the model equation to the experimental data was used the software Scientis. This model 
described the experimental results very well, and the parameter values are shown in Table 6.  
Table 6 - Parameters of Cross model for the range of FucoPol concentrations and temperatures studied 
Concentration 
(wt.%) 
T 
(C) 
0 (Pa.s)  (s) M R2 
0.7 20 0.214 ± 0.002 0.025 ± 0.001 0.650 ± 0.023 0.9999 
50 0.073 ± 0.002 0.005 ± 0.001 0.665 ± 0.061 0.9998 
70 0.045 ± 0.001 0.002 ± 0.000 0.556 ± 0.064 0.9999 
1.0 20 0.651 ± 0.009 0.055 ± 0.003 0.717 ± 0.020 0.9999 
50 0.207 ± 0.010 0.016 ± 0.004 0.603 ± 0.069 0.9993 
70 0.091 ± 0.001 0.005 ± 0.000 0.692 ± 0.039 0.9999 
1.4 20 1.985 ± 0.016 0.120 ± 0.006 0.763 ± 0.022 0.9998 
50 0.475 ± 0.005 0.027 ± 0.001 0.687 ± 0.020 0.9999 
70 0.220 ± 0.002 0.009 ± 0.000 0.687 ± 0.017 0.9999 
2.0 20 10.335 ± 0.151 0.447 ± 0.028 0.762 ± 0.025 0.9998 
50 1.925 ± 0.026 0.073 ± 0.005 0.754 ± 0.028 0.9998 
70 0.776 ± 0.014 0.039 ± 0.004 0.604 ± 0.034 0.9996 
RE, relative derivation error = ∑
(|𝑥𝑒𝑥𝑝,𝑖−𝑥𝑐𝑎𝑙,𝑖|/𝑥𝑒𝑥𝑝,𝑖)
𝑛
𝑛
𝑖=1  was 0.007  RE  0.041 
 
By comparing the experimental results with the model (Table 6) is possible to verify, from the high 
values of R squared and the magnitude of RE (relative derivation error), that exists a good agreement 
with this model. As expected, for all concentrations the 0 and  values decreased with decreasing 
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concentration. Lower  values indicate lower relaxation times of the polymer interactions when subjected 
to shear. The same behavior is observed when the temperature is increased for a constant polymer 
concentration. In addition, it is possible to verify that the value of the dimensionless constant (m) reduces 
as the temperature increases in all concentrations. This fact indicates that as the temperature increases, 
the polymer presents a lower shear thinning behavior, since this value is closer to 0, thereby increasing 
the Newtonian plateau, which can be seen in Figure 4.  
For the spray drying process, it is advisable the matrix solutions to present a low viscosity and high 
polymer concentration in order to obtain an efficient encapsulation (Desai and Park, 2005). From the 
FucoPol solutions viscosity studies, it can be observed a substantial decrease of the viscosity by 
increasing the solutions temperatures, especially for low shear rates values. 
Based on these results, the experimental conditions corresponding to the feed solution for the next 
step of the work were selected: polymer concentration of 1 and 2 wt.% and feed temperatures of 20 and 
70 ºC. It is expected to, among other effects, to perceive the difference in using the feed solutions of 2 
wt.% at 70C and of 1 wt.% at 20C, since they have similar viscosity values. 
 
4.2. Production of FucoPol particles by spray drying 
The FucoPol particles production by spray drying was performed as described in section 3.3. When 
the factorial design is employed for particles production (section 3.3.1), specific drying parameters 
needed to be selected. Drying temperatures of 150 ºC and 200 ºC were chosen in order to test two 
extremes values. For temperatures below 150 ºC the drying process may not occur, since the solution 
is very viscous at 1 wt.% and 2 wt.%, even working with low feed flow rates. In opposite, above 200 ºC 
the FucoPol thermal degradation could take place.  
Regarding the feed temperature, it was selected the ambient temperature (20 C) and the value of 
60 C. The value of 60 C (and not higher) was chosen mainly due technical constraints. In order to the 
solution feed enter the spray dryer at this temperature, the feed vessel had to be heated at a much 
higher temperature, and there was a substantial heat loss through the pumping stream. On the other 
hand, increase more the temperature could lead to changes in the FucoPol properties.  
The outlet air temperature plays an essential role in the quality of the spray dried product. It is 
important to be low to avoid product degradation (Prinn et al., 2002). However, it is not controllable and 
depends on the working conditions, being a measure to control the performance of the drying. The range 
of outlet temperatures used in this study was between 55 ºC and 77 ºC, which is within the values 
referred in literature (Gharsallaoui et al., 2007; Estevinho et al., 2013). 
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4.2.1. Process yield 
The yield of the drying process for all the formulations is presented in Table 7. Value below 38% 
were observed except for the sample S5, which had a yield of 72%. This higher value may be related to 
the possible contamination in the feed tube, since it was the first test to be performed experimentally 
and solutions from previous tests could remain in the tube. Nevertheless, the yield obtained in this study 
were lower compared to those referred in literature, ranging from 30 to 60% for lab-scale spray dryers 
(Johansen et al., 2000 and Tonon et al., 2008). The drying process yield can diverge due to different 
parameters, such as: equipment configuration, physical-chemical characteristics of core and wall 
materials, and drying parameters (flow rate, feed temperature and inlet air temperature). Due to these 
facts, the yield of the spray drying is not mentioned in most of the literature studies.  
Table 7 – Yield of spray drying for the factorial design experiments 
Sample 
FucoPol 
(wt.%) 
Feed 
Temperature (C) 
Inlet air 
Temperature (C) 
Spray Drying 
Yield (%) 
S1 1 20 150 11 
S2 2 20 150 9 
S3 1 60 150 14 
S4 2 60 150 14 
S5 1 20 200 72 
S6 2 20 200 38 
S7 1 60 200 16 
S8 2 60 200 22 
 
In this work, increasing the inlet air temperature, keeping the other parameters unchanged, tends to 
increase the yield of the process. This is related to a higher efficiency of the processes of heat and mass 
transfer and faster water evaporation, when higher inlet temperatures are used. This result is in 
agreement with Tonon et al. (2008) that studied the influence of spray drying conditions on the 
proprieties of acai (Euterpe oleraceae Mart.), with maltodextrin as wall material.  
According to Shu et al. (2006), increasing the feed temperature while keeping the remaining 
parameters unchanged should increase the yield, due to the reduction of the solutions’ viscosity. 
However, in the present study the increase in the feed temperature with a slight increase in yield was 
only observed when the inlet air temperature was maintained at 150C.  
The low yield values can be related to large depositions of solution in the drying chamber without 
being atomized (Johansen et al., 2000) and to the water condensation inside the chamber, which makes 
the particles to adhere to the chamber walls, instead of being collected in the cyclone (Prinn et al., 2002). 
These occurrences are more pronounced when a high feed flow rate is used, which makes difficult the 
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evaporation of water. The used flow rate in this work was very low. Still, the deposition of material inside 
the drying chamber was visually noticed.  
 
4.2.2. Particles characterization 
4.2.2.1. Morphology 
It is important to characterize the particles morphology because they can have a direct impact in 
other properties, namely, they can affect the ability to protect and deliver bioactive compounds (Beirão-
da-Costa et al., 2013). Figures 5 to 12 illustrate the SEM images of the particles produced according to 
the factorial design. Only Figure 5 and 6 show the magnification (D) – second general overview, since 
the behavior of the other particles are very similar.  
 
 
Figure 5 – SEM images of S1 (1 wt.% FucoPol concentration; 20 ºC feed temperature and 150 ºC inlet air temperature). (A) 
spherical particle in the center, (B) cross section of the spherical particle, (C) magnification of the cross section , (D) second 
general overview. 
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Figure 6 – SEM images of S2 (2 wt.% FucoPol concentration; 20 ºC feed temperature and 150 ºC inlet air temperature). (A) 
spherical particle in the center, (B) cross section of the spherical particle, (C) magnification of the cross section , (D) second 
general overview. 
 
 
Figure 7 – SEM images of S3 (1 wt.% FucoPol concentration; 60 ºC feed temperature and 150 ºC inlet air temperature). (A) 
spherical particle in the center, (B) cross section of the spherical particle, (C) magnification of the cross section. 
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Figure 8 – SEM images of S4 (2 wt.% FucoPol concentration; 60 ºC feed temperature and 150 ºC inlet air temperature). (A) 
spherical particle in the center, (B) cross section of the spherical particle, (C) magnification of the cross section. 
Figure 9 – SEM images of S5 (1 wt.% FucoPol concentration; 20 ºC feed temperature and 200 ºC inlet air temperature). (A) 
spherical particle in the center, (B) cross section of the spherical particle. 
B A 
C 
B A 
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Figure 10 – SEM images of S6 (2 wt.% FucoPol concentration; 20 ºC feed temperature and 200 ºC inlet air temperature). (A) 
spherical particle in the center, (B) cross section of the spherical particle, (C) magnification of the cross section. 
Figure 11 – SEM images of S7 (1 wt.% FucoPol concentration; 60ºC feed temperature and 200 ºC inlet air temperature). (A) 
spherical particle in the center, (B) cross section of the spherical particle, (C) magnification of the cross section. 
A B 
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It is possible to observe that even with different drying conditions, the particles of the FucoPol 
presented very similar external morphologies. It is noticeable that in the same microscopic field there 
are particles with different structures (Figures 5 and 6 – D). According to the classification reported by 
Walton (2000), the obtained particles are in the category of skin forming structures (capsules). There 
are particles with smooth walls and, around these particles coexist others, usually smaller, with 
extensive dented surfaces containing concavities. This fact was attributed to the shrinkage of the 
particles during the spray drying process (Loksuman, 2007; Medina-Torres et al., 2013), which can occur 
at low or high inlet air temperatures. At low temperatures, the water diffusion rate is lower and particles 
have more time to shrink. At high temperatures the rapid evaporation and high pressure inside the 
particles may also produce shrinkage (Robert et al., 2012).  
Fang and Bhandari (2010), reported that the typical form of particles formed by spray drying is 
spherical, with an average size of 1-100 µm. In this study, concerning to particles’ size, it is observed 
that there is a large size distribution. The particle diameter ranged from 0.5 µm to 26.7 µm approximately, 
with no substantial differences between the different operating conditions applied. 
Some authors that used other polysaccharides as encapsulating matrices prepared by spray drying 
(Alamilla-Beltrán et al., 2005; Beirão-da-Costa et al., 2013) show in their results that, when the drying 
temperature decreases, it is noticed a higher degree of shrinkage and lower mean size of the particles. 
However, in this study it was verified that decreasing or increasing the drying temperature, while keeping 
Figure 12 – SEM images of S8 (2 wt.% FucoPol concentration; 60ºC feed temperature and 200 ºC inlet air temperature). (A) 
spherical particle in the center, (B) cross section of the spherical particle, (C) magnification of the cross section.  
B A 
C 
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the remaining parameters constant, particles with similar morphologies were obtained (similar quantity 
of dented surface particles and particle sizes). 
Loksuwan (2007) used maltodextrin and modified tapioca starch to encapsulate β-carotene by spray 
drying and reported that particles with maltodextrin have less dented surface comparing to modified 
tapioca starch. The author attributed this difference to the sugar composition, since maltodextrin is a low 
molecular weight sugar and may act as a plasticizer preventing shrinkage of the surface during drying. 
According to Zhang et al. (2000) a plasticizer is important for the formation of spherical forms with 
smooth surface. The addition of plasticizer in the FucoPol solutions could be a good alternative to 
improve the structure of the particles obtained. 
In Table 8 are presented the values of the wall thickness of all samples (Figure 5 to 12 – C). The 
values shown for each type of particle, were obtained in different regions of the cross section. As can 
be seen, the wall thickness does not present a uniform size in the same particle, and it is different 
depending on the drying parameters. However, there is no direct relation between the variables under 
study (feed FucoPol concentration, feed temperature or inlet air temperature), and the wall thickness of 
the particles. 
Table 8 – Wall thickness of the different FucoPol particles 
Sample 1 2 3 4 5 6 7 8 
Thickness 
(nm) 
301 
340 
369 
1094 
239 
567 
222 
439 
369 
177 
638 
851 
254 
423 
469 
449.6 
508 
626 
269 
548 
 
In all tested formulations, the FucoPol surface particles showed no cracks and pores, and the inside 
of all particles is a void volume (Figures 5 to 12 – B), which denotes that the inside can be filled with 
bioactive compounds and the walls may ensure protection and retention, due to the existence of a 
resistant crust. Fernandes et al. (2014), explained that this vacuole formations result from the shrinking 
process that occurs after the hardening of the outer surface followed by the expansion of the air bubbles 
trapped inside the droplets.  
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4.2.2.2. Crystallinity and chemical analysis 
Crystallinity  
The X-ray diffraction patterns of the different FucoPol particles are presented in Figure 13. An 
essentially amorphous nature of the FucoPol particles is noticed, with no characteristic peaks in the 
diffraction patterns. Only a large band is observed with a maximum at a 2Ɵ of about 20º in all particles, 
with no substantial differences among them (Figure 13 (b)). However, it is observed that for sample 6, 
this band almost disappears, suggesting an even more amorphous structure.  
 
 
 
Chemical analysis  
The FTIR spectra of all formulations of the FucoPol particles are shown in Figure 14 (a) and (b).  
According to the study performed by Freitas et al. (2011), all formulations present one broad band 
around 3400 cm-1 that represents O-H stretching of hydroxyls and bound water, which overlaps in part 
with the C-H stretching peak of CH2 groups appearing at 2920 cm-1. The intense band between 1200 
and 900 cm-1 represents skeletal C-O and C-C vibration bands of glyosidic bonds and pyranoid ring. In 
the enlargement (Figure 19 (b)) it is possible to observe a band at 1720 cm-1, which may be attributed 
to the C=O stretching of carbonyls in acyl groups. Similarly, the 1250 cm-1 band may be attributed to the 
C-O-C vibration of acyls. The bands at 1607 cm-1 and 1405 cm-1 can be attributed to the asymmetric 
and symmetric stretchings of carboxylates, respectively. The band at 1564 cm-1 may be related with the 
C=O anti-symmetric stretching vibrations of succinate. Also, the bands 1371 cm-1 and 1340 cm-1, can 
be attributed to the C=O symmetric stretching vibrations. 
As can be seen in Figure 14 (b) samples from 1 to 8 have some differences in the spectra in the 
range from 1200 to 1800 cm-1. All samples show almost the same peaks, but some have different 
intensities. At the peaks of 1720 cm-1 and 1250 cm-1, the samples that were heated to 60 ºC, by varying 
the other parameters, present lower intensities. There are also differences, particularly in the samples 
that have feed temperatures of 20 ºC (S1, S2, S5, S6), while varying the other parameters. It is noted 
Figure 13 – XRD diffractograms of (a) samples 1 to 8 (b) samples 1 to 8 with enlargement 
(a) (b) 
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that in these samples there is no peak at 1564 cm-1, which demonstrates that these vibrations only 
appear in particles from heated feed solutions. Thus, different feed temperature conditions have 
influence in the particles’ chemical bonds. This fact may be related to the proteins of the FucoPol that 
may denatured before entering in the spray drier.   
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
4.2.2.3. Thermal analysis 
Thermogravimetry (TG) and differential scanning calorimetry (DSC) measurements were carried out 
in order to evaluate the thermal behavior of FucoPol particles. It is illustrated only the results of sample 
6 (Figure 15), because the thermal scans are very similar for all samples, indicating that the drying 
parameters do not influence the thermal behavior of FucoPol particles. The other obtained results are 
shown in appendix VI. 
Figure 14 – FTIR spectra of (a) samples 1 to 8 (b) samples 1 to 8 with 
enlargement 
(a) 
(b) 
3400 
2920 
1200 - 900 
1720 
1607 
1564 
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Regarding TG tests, the sample 6 showing three mass loss regions. The first when temperature is 
raised up to 90 ºC, with a mass loss of almost 10%, is attributed to evaporation of water or other volatile 
compounds. The second is observed when the temperature is raised above 268 ºC, corresponding to a 
mass loss of about 70%, which is attributed to biopolymer thermal degradation (Vendruscolo et al., 2009; 
Hosseine et al., 2013). Afterwards, the sample mass continues to decreased at a constant rate until the 
end of experiment (T= 550 ºC), with an overall mass loss of around 80%.  The temperatures 
corresponding to the each mass change peak are clearly observed in the first derivative of the TG curve 
(DTG) with respect to temperature (Hosseine et al., 2013).  
The DSC experiments show an endothermic peak near of 90 ºC, which may be attributed to the 
evaporation of bound water or other volatile compounds, and an exothermic peak at 267.6 ºC, which is 
related to the sample degradation (between 220 ºC and 350 ºC). These results are in agreement with 
the TG analysis. 
 
Figure 15 – DSC/TG analysis of sample 6 
According to the results obtained for all formulations, all particles start to degrade at a temperature 
of approximately 200 ºC, with an exothermic DSC peak at ~260-267 ºC. These particles would not be 
affected by temperature of 200 ºC in spray-drying. Though, the drying temperature used should not be 
much higher than 200 ºC, as assumed in the factorial design.  
 
4.3. Encapsulation of bioactive compounds on FucoPol particles 
According to the experimental factorial design (section 3.3.1), and based on the characteristics of 
the particles obtained (section 4.2.2), the experimental conditions referring to Sample 6 (2 wt.%. 
FucoPol concentration, feed temperature of 20 ⁰C and inlet air temperature of 200 ⁰C) was selected, to 
produced particles with bioactive compounds. The microparticles produced at lower drying temperatures 
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tend to be more porous due to delayed solidification and diffusion of the aqueous phase into the 
dispersed phase (Yeo and Park, 2004). Therefore, it was selected the formulation produced with the 
higher drying temperature (200 ⁰C), which may result in a low initial burst of the content upon bioactives 
release. Regarding to the FucoPol concentration on the feed, the value of 2 wt.%. was selected, as the 
higher the concentration of the wall material, the higher tends to be the encapsulation efficiency. It was 
noticed that the feed temperature did influence the particles characteristics, such as, particles’ chemical 
bonds, thus the lower feed temperature tested (20 ⁰C) was chosen.  
 
4.3.1. Process yield 
The yield of the spray drying process was 26% and 24% for the GA and OEO particles, respectively. 
The GA particles after drying exhibit a greenish color, different from the OEO particles, which have a 
yellowish coloration similar to the particles without the bioactive compounds.  
From the results of spray drying yield of the particles with bioactive compounds is verified that the 
yield of this process is lower comparing with the cited in the literature, which is between 30% and 60% 
(Johansen et al., 2000 and Tonon et al., 2008). These values are consistent with those obtained in 
section 4.2.1, for the FucoPol drying without bioactive compounds. The incorporation of bioactive 
compounds did not change the yield of the process.  
 
4.3.2. Efficiency of encapsulation (EE) and particles loading 
The particle loading and the Efficiency of Encapsulation (EE), with GA and OEO, is presented in 
Table 9.  
Table 9 – EE and Loading of the microparticles with bioactive compounds prepared by spray drying 
Particles Particles loading 
Particles 
loading (wt.%) 
EE 
(wt.%) 
FucoPol particles with GA 0.031 mg GA / mg de particles 3.1% 5.3% 
FucoPol particles with OEO 0.122 mg OEO / mg de particles 12.2% 20% 
It is verified that the highest loading (12.2%) is obtained for the particles with OEO. These results are 
in agreement with the results obtained for chitosan nanoparticles developed with a similar bioactive 
compound. Keawchaoon and Yoksan, (2011) reported the loading of carvacrol, the major component of 
OEO, into chitosan-TPP nanoparticles and it was in the range of 2.7-21.2%. However, Hosseino et al. 
(2013), studied the loading of OEO into chitosan nanoparticles prepared by the method of freeze-drying, 
obtaining a value of the OEO loading in the range between 1.32% and 2.12%. The difference in the 
results may be related to the method used, since in the last, the particles were prepared by freeze-
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drying, proving that the spray drying is a more efficient method for the encapsulation of this compound. 
A possible explanation of the general low values of particles loading may be the volatility of the OEO.   
The particles loading with GA was lower (3.1 wt.%). Relatively to the encapsulation of GA, it is difficult 
to find studies using the spray drying process. Nevertheless, researchers that used other encapsulation 
processes, for different applications (magnetite nanoparticles), referred GA loadings below 7% (Dorniani 
et al., 2014), which could indicate that the obtained values are reasonable.  
Regarding the EE, FucoPol particles with GA present a low value of 5.3 wt.%, which is in agreement 
with the values of the particles loading obtained in this study. Rosa et al. (2013), described superior 
results after encapsulation the GA in three different matrices (chitosan, β-cyclodextrin and xanthan) by 
lyophilization, referred values between 77.5 and 91 wt.% of EE.  
The EE value of the FucoPol particles with OEO was 20 wt.%. This value was in agreement with 
those report by Hosseini et al. (2013), with values that ranged from 5.5 wt.% to 24.7 wt.% for the OEO 
encapsulated using different weight ratios of the chitosan nanoparticles’ matrix. OEO is an easily 
volatized compound when exposed to heat and, one of the reasons for low EE found, may be related to 
the inlet air temperature used in spray drying process (200 ºC). Shu et al. (2006) state that high inlet air 
temperature can break the balance between the evaporation and the particle formation rate, and thus 
cause a low EE.  
 
4.3.3. Particles characterization 
4.3.1.1. Morphology 
Scanning Electron Microscopy 
When the bioactive compounds are encapsulated, the morphology of the particles obtained suffers 
some modifications, when comparing to the particles obtained without bioactives (Sample 6). The SEM 
pictures are presented in Figures 16 and 17.  
 The particles are capsules, with a continuous wall with a rough surface. In these particles occurs 
the same as in FucoPol without bioactive compounds, since smaller particles co-exist around with 
extensive dented surfaces (Figure 16 and 17 – D). In the case of OEO (Figure 17) the particles exhibit 
a more deformation degree of the spherical shape compared to the GA particles.  
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Figure 17 – SEM images of sample FucoPol particles with OEO (2 wt.% FucoPol concentration in the feed; 20 ºC feed 
temperature and 200 ºC inlet air temperature).. (A) spherical particle in the center, (B) cross section of the spherical particle, 
(C) magnification of the cross section , (D)second general overview. 
Figure 16 – SEM images of sample FucoPol particles with GA (2 wt.% FucoPol concentration; 20 ºC feed temperature and 200 
ºC inlet air temperature). (A) spherical particle in the center, (B) cross section of the spherical particle, (C) magnification of the 
cross section , (D)second general overview. 
C 
B A 
D  
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The presence of bioactive compounds leads to a decrease of the particles size, since the diameter 
of the sample 6 ranged from 2 µm to 26.7 µm and FucoPol particles with GA from 1.7 µm to 11.1 µm. 
In the case of OEO, the diameter ranged from 1.2 µm to 8.82 µm. These results are in disagreement 
with those reported by Beirão-da-Costa et al. (2013) regarding the effect of the presence of OEO in the 
particles size, since the authors refer that it leads to an increase of the particles average diameter. This 
fact may be due to the different wall material used (inulin).  
In the presence of bioactive compounds, the particles presented a thicker wall comparatively to the 
sample 6 (Table 10). 
Table 10 – Wall thickness measurements of FucoPol particles (Sample 6 and encapsulates) 
Sample 6 GA OEO 
Thickness 
(nm) 
254 
 
833 
 
625 
500 
 
The wall morphology is different depending on the encapsulated compound. The particles with OEO 
show holes within the particles walls that may be attributed to entrapped oil droplets (Figure 17 – C), 
while in the particles with GA the walls cross section are continuous and dense (Figure 16 – C). It is 
envisaged that the entrapment of GA is carried out within the capsules wall, as it is solubilized in the 
feed solution. Regarding the OEO, it is insoluble in the feed, and an emulsion is fed to the spray drier. 
As such, it may me entrapped either in the interior of the capsules or within the walls, as perceived in 
the SEM images. 
 
Confocal microscopy 
A confocal analysis was carried out in order to verify if the shrinkage of the particles was due to the 
SEM analysis process, as in this technique the samples are placed under vacuum. Figure 18 shows the 
same shrunk shape, which allows concluding that the shrinkage is inherent to the spray drying process.  
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Figure 18 – Confocal microscopy of sample with GA 
 
4.3.1.2. Crystallinity and chemical analysis 
Crystallinity 
When bioactive compounds are present in the capsules (Figure 19), it can be observed an essentially 
amorphous structure with the same pattern as the one of the sample 6 (without bioactives). The GA is 
a highly crystalline solid, with numerous peaks, as illustrated by several authors (Neo et al., 2013; Liu 
et al., 2014). However, the FucoPol particles with GA sample does not exhibit any of the characteristic 
peaks of the gallic acid, which suggests that this compound is fully dispersed within the polymer matrix 
upon capsuled formation.  
 
  
 
Chemical analysis 
To examine the possible interactions and structural changes between the bioactive compounds and 
the FucoPol particles, FTIR analyses were performed. Figure 20 shows the FTIR spectra of (a) sample 
6 without bioactive compounds, (b) FucoPol particles with GA and (c) GA alone.  
Figure 19 – XRD diffractograms of (a) samples 6, FucoPol with GA and FucoPol with OEO (b) samples 6, FucoPol with GA 
and FucoPol with OEO with enlargement 
(a) (b) 
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The most important bands in the GA molecule are the peak at 1700 cm-1, referring to the carbonyl 
group COOH, the peak at 3200 – 3500 cm-1 that is attributed to the phenolic O-H stretch and the peak 
at 1029 cm-1 , which corresponds to the benzene ring vibration (Hu et al., 2013; Rosa et al., 2013; Martí 
et al., 2014). According to Hu et al. (2013), the bands at 1537 cm-1 and at 1303 cm-1 that appear in the 
spectrum of GA are attributed to the aromatic C=C vibrations. The main bands of GA are not present in 
FucoPol particles with GA.  
However, there are some differences in the FucoPol particles with GA spectrum in comparison to 
the empty capsules and GA alone, namely, the appearance of one band at 1583 cm-1 and another at 
1334 cm-1. These new bands that appear at the FucoPol particles with GA spectrum, indicate structural 
modifications that may be caused by interactions/reactions between the GA and FucoPol. Moreover, in 
comparison with the FTIR spectrum of Sample 6, the addition of GA on FucoPol particles resulted in a 
larger intensity of some bands (the overlap of the spectra can be seen in appendix V (a)). Although the 
FTIR spectrum of GA is difficult to compare with the FucoPol particles with GA, since in the FucoPol 
particles with GA the amount of GA encapsulated is lower.  
The obtained results demonstrate that GA is encapsulated in the FucoPol particles, establishing new 
chemical interactions. GA can form hydrogen bonds because it has polarizable hydroxyl of phenolic and 
carboxylic groups, both intramolecular as well as intermolecular (Rosa et al., 2013). Thus, it is suggested 
that possible interactions between GA and FucoPol matrix may are hydrogen bonds.  
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Figure 21 shows the FTIR spectra of (a) sample 6 without bioactive compounds, (b) FucoPol particles 
with OEO and (c) only OEO. The OEO spectrum shows characteristic peaks at 2956 cm-1 (-CH 
stretching), 1589 cm-1 (N-H), 1438 cm-1 (CH2), 1284 cm-1 (C-O-C stretching), 1112 cm-1 (C-O-C 
stretching) and 917 cm-1 (C-H) (Hosseini et al., 2013). However, all the above characteristic peaks 
disappear in the spectrum of FucoPol particles with OEO, appearing only the same peaks as in sample 
6 (the overlap of the spectra can be seen in appendix V (b)).  
In contrast with the GA, all the peaks that appear in the FucoPol particles with OEO have the same 
wavenumber of the sample 6. There are peaks, which intensity decreases slightly, namely at 1720 cm-
1 and, 1405 cm-1 and one at 1250 cm-1, which intensity decreases, which may be due to the presence 
of OEO in the FucoPol particles. The results indicate no substantial chemical modifications or 
interactions between the OEO and the FucoPol. This fact may be due to the hydrophobic and hydrophilic 
character of the OEO and FucoPol, respectively.   
 
 
Figure 20 – FTIR spectra of (a) Sample 6 (b) FucoPol particles with GA (c) GA  
3400 
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4.3.1.3. Thermal analysis 
The thermal analysis of the FucoPol particles with bioactive compounds was evaluated, in order to 
assess the thermal stability of these compounds and their interactions with FucoPol. In TG of GA (Figure 
22) it is observed four steps of mass loss. The first occurs at a temperature around 90 ºC, with a mass 
loss of almost 10%, which may be attributed to adsorbed water evaporation. The second is observed 
when the temperature reaches 264 ºC, ending at a mass loss of near 40%, and the third occurs when 
the temperature is raised to near 330 ºC, presenting a mass loss of 65% in the end. Afterwards, the 
sample mass continues to decrease at a constant rate until the end of the experiment (T=550 ºC), with 
an overall mass loss of 80%.  
According to Rosa et al. (2013), the melting point of the GA occurs at the temperature of: 100 ºC, 
221 ºC and 250 ºC, depending on the type of GA isomer. The DSC scan of GA presents a large 
endothermic transition at 264 ºC, which may be attributed to its melting point. However, this value 
coincides with the thermal degradation of GA right after its melting point, since this temperature value 
corresponds to that at which a substantial mass loss starts to be observed by TG.  
When looking at TG analysis of FucoPol particles with GA (Figure 23) differences are perceived, 
namely the existence of one major mass loss step (T= 269 ºC), in the temperature between 200 ºC and 
Figure 21 – FTIR spectra of (a) Sample 6 (b) FucoPol particles with OEO (c) OEO 
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1607 
1250 
1405 
(a) 
(b) 
 
(c) 
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350 ºC, instead of two mass loss steps observed for GA. Regarding the DSC scan of FucoPol particles 
with GA, it is also different, either from that of the FucoPol particles without GA – sample 6 (Figure 15) 
or that of GA (Figure 22). Namely, the exothermic band detected at 267 ºC in the sample 6, attributed 
to thermal degradation, is broadened between 250 ºC and 350 ºC in the FucoPol particles with GA. For 
the particles with GA, the FucoPol thermal properties seem to superimpose to those of GA, as the TG 
and DSC scans are more close to that of FucoPol without GA (sample 6). This fact may be attributed to 
the low GA loading (3.1 wt.%). Nevertheless, the results seem to indicate the inexistence of separated 
phases, with a good GA dispersion within the biopolymer, which is in agreement with the XRD results.  
 
Figure 22 – DSC/TG analysis of GA 
 
 
Figure 23 – DSC/TG analysis of FucoPol particles with GA  
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Regarding the OEO, the TG assay (Figure 24) shows that this compound has only one step of mass 
loss of 100%, corresponding to total volatilization. The FucoPol particles with OEO (Figure 25) have 
three steps (similar to sample 6). The first mass loss step is when the temperature is raised to 90 ºC, 
with a mass loss of almost 10%. The second occurs when the temperature is raised to 260 ºC, 
corresponding to the higher mass loss with a value of 50%. Afterwards, the sample mass continues to 
decrease at a constant rate until the end of the experiment (T= 550 ºC), with an overall mass loss of 
around 70%. Similar results were reported by Hosseini et al. (2013) for the thermal behavior of chitosan 
nanoparticles with OEO. 
The DSC experiments of OEO (Figure 24) show an endothermic peak at 120 ºC, which is due to the 
material evaporation, whereas the FucoPol particles with OEO (Figure 25) have one endothermic peak 
near of 50 ºC, which may be attributed to the evaporation of bound water or to volatile compounds from 
FucoPol particles or could be due to the loss of free OEO that was not encapsulated (Keawchaoon and 
Yoksan, 2011). In the FucoPol particles with OEO exists an exothermic peak at 260 ºC, which is related 
to the sample degradation (between 200 ºC and 350 ºC). These results of DSC are in agreement with 
the TG analysis.  
The DSC of sample 6 (empty FucoPol capsules) exhibits an exothermic peak at 267.6 ºC (Figure 
15). With the encapsulation of OEO, the particles show an exothermic peak at 260 ºC (Figure 25). This 
decrease could be attributed to the encapsulation of the OEO. The DSC of FucoPol particles with OEO 
did not show any substantial endothermic transition that could be attributed to volatilization of 
encapsulated OEO. This fact may be attributed to its volatilization at lower temperature (endothermic 
peaks between 50 ºC and 100 ºC, Figure 25), to the low oil loading or to its degradation along with the 
FucoPol. 
 
Figure 24 – DSC/TG of OEO  
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Figure 25 – DSC/TG of FucoPol particles with OEO 
 
4.3.4. Release studies 
Release assays of encapsulated bioactive compounds in microparticles, prepared with 2 wt.% of 
FucoPol concentration, feed temperature of 20 ºC and drying temperature of 200 ºC, were carried out. 
Prior to the release tests with encapsulated GA and OEO, it was necessary to perform a test with the 
sample 6 (without bioactive compounds), in both media (SGF and SIF), in order to verify if FucoPol 
presents itself any absorbance. It was found that the FucoPol showed some absorbance at 280 nm. 
This may be related to the composition of FucoPol, namely, the protein content (<5 wt.%), which are 
remnants of the cultivation broth that was not removed in dialysis. Consequently, the absorbance of the 
medium containing empty FucoPol particles was subtracted to the absorbance values of the release 
medium of each experiment with encapsulated bioactives.  
In all release studies of encapsulated OEO and GA in both simulated fluids, when the particles are 
placed into the medium they remained in suspension and occurred some particles agglomeration. 
However, after some time (about 10 minutes) the particles begun to dissolve in the medium. This 
envisages that the particles’ content was not immediately released to the medium, being a progressive 
release.  
The in vitro release profiles of GA and OEO from particles, using two simulated fluids as release 
media, are illustrated in Figure 26 and 27, respectively. The release curves were expressed by mass of 
compound released in relation to the used microparticles’ mass versus time.  
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Figure 26 – In vitro release profile of GA from FucoPol microparticles in SGF (■) and SIF (▲) 
 
 
Figure 27 - In vitro release profile of OEO from FucoPol microparticles in SGF (■) and SIF (▲) 
 
In both studied release profiles it is possible to distinguish two zones: an initial rapid release period 
(“burst effect”), after which a plateau is reached meaning that the mass transfer has ceased. In the case 
of OEO, the release rate during the first 35 minutes is lower. These phenomena are in agreement with 
the in vitro release studied from encapsulated OEO in chitosan nanoparticles prepared by spray drying 
by Hosseini et al. (2013).  
Hosseini et al. (2013), associated the initial release to the bioactive compound molecules adsorbed 
on the surface of the particles and entrapped near the surface. As the dissolution rate of the polymer 
near the surface increases, the amount of released compound will also increase. On the other hand, 
Yeo and Park (2004) described the initial release in two ways: it can happen by the mentioned above 
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and it can also occur due to the particles’ morphology, namely, it can be released by cracks or through 
pores (as explained in the literature review), that are formed during the encapsulation process. Beirão 
da Costa et al. (2013) described the second phase as the phase when the release rate becomes 
relatively slow, which means that the compounds release has fully occurred due to some polymer 
degradation and the bioactive compounds concentration within the particles remains approximately 
constant over the time. There may exist a third phase, which corresponds to the erosion of the FucoPol 
matrix due to its dissolution in the medium and to the total release of the bioactive compounds (Robert 
et al., 2012). However, this stage was not observed in this study because the releases were performed 
in a short time. 
According to profiles, it can be seen that the GA release from FucoPol particles (Figure 26), in both 
media, has an initial rapid release during the first 5 minutes, and a following period when the release 
profile becomes constant. In contrast, the initial release of OEO (Figure 27) occurs a while longer, during 
to approximately 35 minutes, with the constant release starting after 40 minutes, in both media. This 
fact is in agreement with that was observed during the tests, i.e., after a few minutes the dissolution of 
the particles becomes observable.  
Table 11 presents the maximum bioactives mass released from the particles and the compounds 
initial release rate. 
Table 11 – Initial release rate and maximum mass released (wt.%) from the microparticles with bioactive compounds 
 Medium 
FucoPol particles 
with OEO 
FucoPol particles 
with GA 
Maximum mass released 
SGF 100 % 32 % 
SIF 90 % 100 % 
Initial release rate 
(mg bioactive compounds / min) 
SGF 6.0 2.1 
SIF 7.8 8.2 
 
The obtained results show different release behaviors, obtained from different encapsulated 
compounds in the FucoPol particles in the different media used. It is possible to verify that OEO was 
fully released in SGF medium and it was almost completely released in SIF medium. This different 
behavior can be explained by the fact that the OEO is a hydrophobic compound. Thus, it can be better 
dissolved in acidic media, and is less retained in the FucoPol matrix, which allows a higher compounds 
release. In the case of the basic medium (SIF), 10% of the compounds remained retained until the end 
of the assay. Similar results were reported with chitosan nanoparticles (Hosseini et al., 2013), where an 
initial release of 82% of encapsulated OEO followed by a slow release at a constant rate was observed.  
Regarding the FucoPol particles with encapsulated GA, different results were expected because the 
structure analysis (section 4.3.1.2) of these particles indicates interactions between GA and FucoPol. 
GA is inside the particles walls, a fact that was indicated by FTIR and XRD analysis.  
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The release profiles show that most of encapsulated GA was retained in SGF (68%) but was totally 
released in SIF. FucoPol particles with GA that were immersed in SGF were those that presented a 
higher entrapment of the compound, and exhibited the lowest initial burst release (2.1 mg GA / min). 
More extensive studies focused on the type of interactions and/or chemical bonds established between 
FucoPol and GA upon the encapsulation process are necessary, in order to clearly explain the different 
release profiles.  
The behaviour presented for GA release is the opposite when compared to that referred in the study 
of Hu et al. (2013). This study presents the release of GA encapsulated in silica nanoparticles in HCl 
medium (pH = 1.2) and in a buffer solution (pH = 5.33). The results showed a major total amount of GA 
released in acidic medium (approximately 85%), compared to about 70% in basic medium. This different 
behaviour should be essentially due to the different nature of wall material used.  
 
4.3.5. Optical microscopy  
The following pictures show the particles with bioactive compounds, and were obtained by optical 
microscopy at two instants of the release studies in the different media (SGF and SIF).  In each set of 
images is displayed an image A, which corresponds to the particles after 5 minutes and an image B that 
shows the particles after 60 minutes, both under stirring.   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 28 – FucoPol particles with GA in SGF medium with agitation - (A) after 5 minutes and (B) 
after 60 minutes. 
A B 
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In all pictures, after 5 minutes of agitation (Figure 28 to 31 – A), the particles still present a spherical 
shape. However, some particles fragments are already perceived, indicating the partial disintegration.  
In the case of the OEO (Figure 30 and 31 – A), the medium appeared to be more viscous, probably 
due to the OEO release, which is in agreement with the release studies where the OEO was fully 
released in SGF and almost completely released in SIF medium (section 4.3.4). The observations of 
FucoPol particles with OEO in the SIF medium (Figure 31-A) was more difficult to carry out, because 
most of these particles were already disintegrated and it was difficult to find entire particles.  
Figure 29 – FucoPol particles with GA in SIF medium with agitation - (A) after 5 minutes and 
(B) after 60 minutes. 
A B 
Figure 30 – FucoPol particles with OEO in SGF medium with agitation - (A) after 5 minutes 
and (B) after 60 minutes. 
A B 
Figure 31 – FucoPol particles with OEO in SIF medium with agitation - (A) after 5 minutes 
and (B) after 60 minutes. 
 
A B 
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After 60 minutes under agitation (Figure 28 to 31 – B), all particles were disintegrated. These 
disintegration may be due to the hydrophilicity of the spray dried particles, which promotes the water 
penetration in the capsules structure, decreasing their mechanical resistance. Still, there was not a 
complete dissolution of the capsules after one hour. The release is likely to occur by diffusion, before 
and after particles walls swelling, in the first few minutes. Additionally, in accordance with section 2.5, 
since the FucoPol is an amorphous material (concluded from XRD analysis), the diffusion tends to be 
higher. After that, particles mechanical degradation also played an important role. As such, according 
to literature review (section 2.5), it can be considered a release system that combines release by 
diffusion, swelling and mechanical degradation. 
 
4.3.6. Antioxidant activity of the model compounds before and after 
encapsulation 
The results of the analysis of the antioxidant activity with DPPH and FRAP methods are summarized 
in Table 12. The antioxidant activity of the GA and OEO after and before the encapsulation process, 
was evaluated.  
In the case of GA, since for the preparation of its particles it is required that the GA keeps under 
stirring during 12 hours upon FucoPol dissolution before spray drying, as described in the section 3.4, 
it was necessary to carry out a parallel experiment to verify the antioxidant activity of the GA after stirring 
during 12 hours, in order to monitor possible loss of antioxidant power during that time. In the case of 
OEO it was not necessary to perform an extra assay because it was not needed long time stirring of this 
compound before drying.  
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Table 12 – DPPH and FRAP assay results. Data are expressed as mean (expressed in TEAC= concentration of trolox (µmol 
/ g of bioactive compounds ± SD) 
METHODS 
BEFORE 
ENCAPSULATION 
AFTER 
AGITATION 
AFTER 
ENCAPSULATION 
GA 
DPPH TEAC 13.9 ± 0.8 17.2 ± 0.7 20.8 ± 0.8 
FRAP 
TEAC 16.6 ± 3.2 20.3 ± 1.0 22.2 ± 6.3 
Iron Sulfate* 49.9 ± 8.6 59.9 ± 2.6 54.3 ± 8.8 
OEO 
DPPH  TEAC 0.026 ± 0.018 - 0.154 ± 0.104 
FRAP 
TEAC 
Iron Sulfate* 
0.415 ± 0.060 - 0.714 ± 0.494  
1.262 ± 0.161 - 2.774 ± 1.336 
* Results of FRAP iron sulfate are expressed in concentration of iron sulfate (µmol) / g of the bioactive compounds. 
The antioxidant activity of the bioactive compounds before and after encapsulation was expressed 
using the average TEAC (moles of Trolox (µmol) / g of the bioactive compounds). The TEAC values 
indicate the mass of antioxidant (bioactive compounds) required to have the same activity as of 1 µmol 
of Trolox. In the case of FRAP method with iron sulfate the antioxidant capacity was expressed by the 
average amount of iron sulfate (µmol) / g of bioactive compounds. 
Regarding the GA, the results from both methods (DPPH and FRAP), suggest that there was no loss 
of antioxidant capacity after encapsulation. Based on the observations, it can be concluded that the 
processing and drying temperatures are not harmful for the GA properties, and by incorporating this 
compound into the FucoPol particles it is possible to retain their antioxidant activity. However, the GA 
before encapsulation showed lower values of antioxidant activity than after the encapsulation. This fact 
may be due to the FucoPol itself, which may be reacting with the DPPH radical and FRAP reagent, or 
due to some experimental error associated with this experience.  
Concerning the values of GA antioxidant activity after 12 hours of stirring, they could theoretically 
decrease, since the GA is subjected to contact with oxygen during that time, which was not the case.  
From the results obtained for the OEO, it is evident that this compound presents a lower antioxidant 
power compared to the results observed for the GA. The results of the antioxidant capacity of the OEO 
from both methods (DPPH and FRAP) are very low. It could indicate that these are not the best methods 
Chapter 4.  Results and Discussion                              FucoPol as encapsulating matrix of bioactive compounds 
__________________________________________________________________________________________ 
63 
 
for measuring the potential of this compound. However, Kulisic et al. (2004) have shown that it is not 
the case. They have studies different methods for testing the antioxidant activity of OEO, and it was 
denoted that this compound presents a significant antioxidant activity with some methods, comparatively 
to some other compounds such as ascorbic acid. Also, it was demonstrated that CHO, i.e., the oxygen 
containing a compounds fraction (composed by carvacrol, thymol, borneol and 1-Octen-3-ol), was the 
most potent antioxidant fraction on the OEO suggesting that the higher activity of this compound is due 
to its polar constituents. These author’s investigation showed that the method used in this study (DPPH) 
is independent of the substrate polarity, and the substrate polarity does not affect the DPPH scavenging 
activity, which confirms the values presented in this work. No data has been reported in the literature 
for FRAP assay of OEO.  
In addition, the values of the antioxidant activity of the encapsulated OEO are higher than those 
showed by the compound before encapsulation. This fact is consistent with the assumptions stated 
above about the FucoPol reaction in these methods. The results indicate that the FucoPol matrix 
protects the OEO from oxidation.  
Beirão da Costa et al. (2012), determined the antioxidant activity of OEO encapsulated in rice starch, 
inulin, carboxymethylcelulose, sucrose and gelatin matrices by using other different assays, the Oxygen 
Radical Absorbance Capacity (ORAC) and the Hydroxyl Radical Adverting Capacity (HORAC). These 
methods were used to evaluate the antioxidant capacity of the samples towards peroxyl radical and 
evaluate the hydroxyl radical prevention capacity of a sample using fluorescein as probe. Those authors, 
concluded that the encapsulated OEO maintained its antioxidant activity for all tested encapsulation wall 
materials, since the samples presented values quite similar to that obtained for free OEO.  
It is not surprising that different methods, would give different results because they are based on 
different principles. A number of studies of the antioxidant activities of essential oils reported that the 
OEO has a considerable antioxidant, due to its richness in thymol and carvacrol. Kulisic et al. (2004) 
shows that a single testing method is insufficient to estimate the antioxidant activity of OEO, since, each 
method measures the capacity of antioxidants in scavenging specific radicals (Guo et al., 2003). It is 
recommended the combination of various methods to correctly evaluate the antioxidant activity. 
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Chapter 5 – Conclusions and Future Work 
 
The elaboration of this thesis has the intention to study the capability of a new microbial 
exopolysaccharide, the Fucopol, to be used as encapsulating matrix by a feasible, fast and economical 
process, the spray drying. In order to evaluate the characteristics of the particles produced by this 
technique, it was performed an experimental factorial design with the independent variables of polymers’ 
concentration, feed temperature and inlet air temperature. 
FucoPol particles were successfully prepared by the spray drying and all the formulations that were 
made have formed particles with an average size of 0.5 µm to 26.7 µm and an irregular wall thickness 
with a mean size of about 222 nm to 1094 nm. The particles present differentiated morphologies, without 
crack. The biggest particles have spherical shape with smooth surface but around them exist other 
particles, with smaller size and an extensive dented surfaces with concavities. Since these morphologies 
were observed in all formulations, it is possible to conclude that they are not related with the drying 
parameters but with the FucoPol itself.  
It was selected one set of experimental conditions (2 wt.% FucoPol concentration, drying 
temperature of 200 ⁰C and a feed temperature of 20 ⁰C), in order to establish how these particles behave 
as encapsulating matrix of bioactive compounds. GA and OEO were used as models. 
The particles with bioactive compounds presented similar morphologies as the particles without 
them. Nevertheless, the average particles size became smaller and the thickness of the wall became 
higher. On the other hand, the particles with encapsulated OEO show cavities within the walls cross 
section that may be attributed to entrapped oil droplets.  
All particles have an amorphous structure. In the case of OEO particles, FTIR analysis demonstrated 
the presence of this compounds within the particles but without interactions with the matrix. However, 
when the GA is incorporated, this compound behaves differently, being denoted the existence of new 
interactions between the GA and the FucoPol matrix.  
In vitro release studies under simulated GF and IF conditions confirmed that the FucoPol was able 
to encapsulate GA and OEO, with a loading of 0.031 and 0.122 mg/mg particles, respectively. The OEO 
exhibits a release profile with almost total release in both SGF and SIF media. Although, GA in SIF 
behaves similar with approximately 100% of the compound being released after a few minutes, in SGF, 
the results of the release profile are different, confirming the previously described, i.e. that exists some 
interaction with the matrix. In SGF, most of the GA was retained in the FucoPol particles (68%), which 
means that the particles resist to the acidic medium of the stomach and passes into the intestine. It is 
possible to conclude that a sustained release could improve the lifetime of this compound in the body 
system. 
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From studies of optical microscopy it was possible to understand that the release mechanism of the 
compounds is given by a combination of various systems, such as, diffusion, swelling and some 
mechanical degradation.  
The results of DPPH and FRAP methods showed that, after encapsulation, the antioxidant activity of 
the compounds is maintained, and the processing and drying temperatures do not affect the properties 
of these compounds. The FucoPol matrix is able to maintain the stability of these compounds and protect 
them from environmental conditions.  
The characteristics of FucoPol as encapsulating matrix indicated its potential on diverse applications. 
The information obtained in this study will open a wide range of applications, particularly its use in food, 
as food packaging or delivery systems in biomedical, pharmaceutical and cosmetics industries, which 
encourages further research work. 
According to all the results presented in this thesis, further studies remains to perform, such as: 
 Confocal microscopy analysis, in order to detect the presence of the compounds inside the particles 
and ascertain how they are arranged in the FucoPol particles, with the goal to confirm the DSC and 
FTIR analysis;  
 
 The study the use of other polymers or compounds (e.g. reticulating agents), which can be connected 
to the FucoPol matrix, in order to produce a strong structural matrix and improve the retention of 
bioactive compounds; 
 
 Sequential in vitro release studies, with the same particles with encapsulated compounds, being 
subjected to SIF right after their contact with SGF, to simulate the normal functioning of the human 
gastrointestinal tract;  
 
 The encapsulates incorporation in food systems and the evaluation of the release profile;  
 
 According to the obtained results of the release profiles, it would be interesting to observe what 
happens to the chemical interactions on each medium. A more consistent analysis, such as NMR 
spectroscopy, should be performed to evaluate these interactions; 
 
 It will be useful to examine the performance of FucoPol particles for encapsulation of others quantities 
of GA and OEO, or other bioactive compounds, and evaluate the release profile.  
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Appendix I. Standard curves for calculate loading capacity of bioactive compounds in FucoPol 
particles  
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Appendix II. Calibration curves for study release of bioactive compounds in FucoPol particles  
 
Calibration curve of GA in SGF 
 
 
Calibration curve of GA in SIF 
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Calibration curve of OEO in SGF 
 
 
Calibration curve of OEO in SIF 
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Appendix III. Calibration curve of Trolox with DPPH method at different Trolox solutions ()  
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Appendix IV. Calibration curves with the FRAP method at different solutions  
 
 
Calibration curve of the Trolox with the FRAP method at different Trolox solutions () 
 
 
 
Calibration curve of the Iron sulfate with the FRAP method at different Sulfate Ferrous solutions () 
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Appendix V. FTIR images  
 
a) FTIR spectra of FucoPol particles with GA and Sample 6 
 
 
b) FTIR spectra of FucoPol particles with OEO and Sample 6 
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Appendix VI. DSC/TG images of sample 1 to 8 
 
Sample 1 (1 wt.% FucoPol concentration; 20 ºC feed temperature and 150 ºC inlet air temperature) 
presents a mass loss of almost 70%. The sample degradation occurs between 220 ºC and 350 ºC, with 
an exothermic peak at 264.5 ºC.  
 
 
Sample 2 (2 wt.% FucoPol concentration; 20 ºC feed temperature and 150 ºC inlet air temperature) 
presents a mass loss of almost 80%. The sample degradation occurs between 220 ºC and 350 ºC, with 
an exothermic peak at 267 ºC.  
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Sample 3 (1 wt.% FucoPol concentration; 60 ºC feed temperature and 150 ºC inlet air temperature) 
presents a mass loss of almost 55%. The sample degradation occurs between 220 ºC and 350 ºC, with 
an exothermic peak at 260 ºC.  
 
 
Sample 4 (2 wt.% FucoPol concentration; 60 ºC feed temperature and 150 ºC inlet air temperature) 
presents a mass loss of almost 70%. The sample degradation occurs between 200 ºC and 350 ºC, with 
an exothermic peak at 263 ºC. 
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Sample 5 (1 wt.% FucoPol concentration; 20 ºC feed temperature and 200 ºC inlet air temperature) 
presents a mass loss of almost 70%. The sample degradation occurs between 220 ºC and 350 ºC, with 
an exothermic peak at 267 ºC.  
 
 
Sample 6 (2 wt.% FucoPol concentration; 20 ºC feed temperature and 200 ºC inlet air temperature) 
presents a mass loss of almost 80%. The sample degradation occurs between 220 ºC and 350 ºC, with 
an exothermic peak at 267.6 ºC.  
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Sample 7 (1 wt.% FucoPol concentration; 60 ºC feed temperature and 200 ºC inlet air temperature)  
presents a mass loss of almost 70%. The sample degradation occurs between 200 ºC and 350 ºC, with 
an exothermic peak at 264.5 ºC. 
 
 
Sample 8 (2 wt.% FucoPol concentration; 60 ºC feed temperature and 200 ºC inlet air temperature) 
presents a mass loss of almost 70%. The sample degradation occurs between 200 ºC and 350 ºC, with 
an exothermic peak at 262 ºC. 
 
 
 
 
 
